Thanks @akanter great work
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for September 27, 2020.
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
This release included a few concepts for PIH plus there were over 800 concept map changes to combination drugs to add RxNORM maps. The process of adding RxNORM CUIs to multi-ingredient drugs will continue over the next few releases.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
Concepts added for this release:
“concept_id” “name” “Class” “Datatype” “description” “166086” “Maternal ARV (text)” “Question” “Text” \N “166086” “Antiretroviral received by mother (text)” “Question” “Text” \N “166085” “PMTCT timing” “Question” “Coded” \N “166085” “Timing of maternal administration of antiretrovirals” “Question” “Coded” \N “166085” “Period of ARV treatment during pregnancy” “Question” “Coded” \N “166084” “Mother changed antiretroviral medications during pregnancy due to side effects of drug” “Question” “Coded” \N “166083” “Before birth” “Misc” “N/A” \N “166083” “Antenatal” “Misc” “N/A” \N “166082” “Pain score” “Question” “Numeric” “Numeric value between 0-10 with 10 being highest pain experienced” “166081” “Denver developmental screening test” “Procedure” “N/A” “Administration of a developmental screening test” “166080” “Intensity of menstrual flow” “Finding” “Coded” \N “166080” “Quantity of menstrual flow” “Finding” “Coded” \N “166079” “Date of LNMP” “Finding” “Date” \N “166079” “Date of last normal menstrual period” “Finding” “Date” \N “166078” “Unnatural death” “Misc” “N/A” “Death caused by external process.” “166077” “Aviptadil” “Drug” “N/A” \N “166077” “RF-100” “Drug” “N/A” \N “166076” “Third” “Misc” “N/A” “Number three in an ordinal list” “166076” “3rd” “Misc” “N/A” “Number three in an ordinal list” “166075” “2nd” “Misc” “N/A” “Number two in an ordinal list” “166075” “Second” “Misc” “N/A” “Number two in an ordinal list” “166074” “First” “Misc” “N/A” “Number 1 in an ordinal list” “166074” “1st” “Misc” “N/A” “Number 1 in an ordinal list” “166073” “ARV treatment line” “Question” “Coded” “Current treatment "line" of therapy with antiretrovirals” “166073” “ART treatment line” “Question” “Coded” “Current treatment "line" of therapy with antiretrovirals” “166073” “Antiretroviral treatment line” “Question” “Coded” “Current treatment "line" of therapy with antiretrovirals” “166072” “SRB” “Misc” “N/A” “Country in Eastern Europe” “166072” “Republic of Serbia” “Misc” “N/A” “Country in Eastern Europe” “166071” “Year of previous pregnancy” “Question” “Numeric” “Four digit year of immediate previous pregnancy” “166070” “Darunavir / Etravirine” “Misc” “N/A” “ARV regimen” “166070” “DRV-ETV” “Misc” “N/A” “ARV regimen” “166070” “DRV + ETV” “Misc” “N/A” “ARV regimen” “166069” “RAL + ETV” “Misc” “N/A” “ARV regimen” “166069” “RAL-ETV” “Misc” “N/A” “ARV regimen” “166069” “Raltegravir / Etravirine” “Misc” “N/A” “ARV regimen” “166068” “RAL + DRV/r” “Misc” “N/A” “ARV Regimen” “166068” “RAL-DRV/r” “Misc” “N/A” “ARV Regimen” “166068” “Raltegravir / Darunavir / Ritonavir” “Misc” “N/A” “ARV Regimen” “166067” “Tier 4” “Misc” “N/A” \N “166066” “Tier 3” “Misc” “N/A” \N “166065” “Tier 2” “Misc” “N/A” \N “166064” “Tier 1” “Misc” “N/A” \N “166063” “Immunization priority tier” “Question” “Coded” “The priority order for persons who should be vaccinated/immunized.” “166063” “Vaccination priority” “Question” “Coded” “The priority order for persons who should be vaccinated/immunized.” “166062” “Republic of Kosovo” “Misc” “N/A” “A partially-recognized country in south east Europe.” “166062” “RS-KM” “Misc” “N/A” “A partially-recognized country in south east Europe.” “166062” “Kosovo” “Misc” “N/A” “A partially-recognized country in south east Europe.” “166061” “Persistent parotid enlargement” “Symptom/Finding” “N/A” \N “166061” “Persistent parotid swelling” “Symptom/Finding” “N/A” \N “166060” “Oral sex” “Finding” “N/A” \N “166060” “Oral-genital stimulation” “Finding” “N/A” \N “166059” “Clinically-indicated lab” “Procedure” “N/A” \N “166058” “Routine scheduled lab” “Procedure” “N/A” \N “166057” “Patient condition/problem the same” “Finding” “N/A” \N “166057” “Patient condition/problem unchanged” “Finding” “N/A” \N “166056” “Patient condition/problem worsened” “Finding” “N/A” \N “166056” “Patient condition/problem worse” “Finding” “N/A” \N “166055” “Patient condition/problem improved” “Finding” “N/A” \N “166055” “Patient condition/problem better” “Finding” “N/A” \N “166054” “Patient on antiretroviral regimen containing D4T” “Question” “Coded” \N “166053” “Patient on AZT, 3TC and either EFV or NVP containing antiretroviral regimen” “Question” “Coded” \N “166053” “AZT + 3TC + (EFV or NVP)” “Question” “Coded” \N “166052” “TDF + 3TC + (EFV or NVP)” “Question” “Coded” \N “166052” “Patient on TDF, 3TC and either EFV or NVP containing antiretroviral regimen” “Question” “Coded” \N “166051” “Able to be aware of self” “Finding” “N/A” \N “166051” “Self-aware” “Finding” “N/A” \N “166050” “Elevated mood” “Finding” “N/A” \N “166049” “Non-HIV/Syphilis STD treatment indicated” “Question” “Coded” \N “166048” “Mother’s maturity level during previous pregnancy” “Question” “Coded” \N “166047” “VLDL (mg/dL)” “Test” “Numeric” \N “166047” “Very low density lipoprotein measurement (mg/dL)” “Test” “Numeric” \N “166046” “High-density lipoprotein cholesterol measurement (mg/dL)” “Test” “Numeric” \N “166046” “HDL (mg/dL)” “Test” “Numeric” \N “166045” “LDL (mg/dL)” “Test” “Numeric” \N “166045” “Low-density lipoprotein cholesterol (mg/dL)” “Test” “Numeric” \N “166045” “Serum or plasma low-density lipoprotein cholesterol measurement (mg/dL)” “Test” “Numeric” \N “166044” “Adult” “Finding” “N/A” “Age >=25 years old” “166043” “Late adolescent/young adulthood period” “Finding” “N/A” “Age >=18 and <25 years old” “166043” “Late adolescence” “Finding” “N/A” “Age >=18 and <25 years old” “166042” “Middle adolescent period” “Finding” “N/A” “Ages >=15 and <18 years old” “166042” “Middle adolescence” “Finding” “N/A” “Ages >=15 and <18 years old” “166041” “Early adolescent period” “Finding” “N/A” “Ages > 10 and < 15 years old” “166041” “Early adolescence” “Finding” “N/A” “Ages > 10 and < 15 years old” “166040” “Total cholesterol (mmol/L)” “Test” “Numeric” \N “166040” “Serum or plasma total cholesterol measurement (mg/dL)” “Test” “Numeric” \N “166039” “Serum or plasma triglyceride measurement (mg/dL)” “Test” “Numeric” \N “166039” “Triglycerides (mg/dL)” “Test” “Numeric” \N “166038” “Serum Ca” “Test” “Numeric” \N “166038” “Serum calcium (mmol/L)” “Test” “Numeric” \N
2 Likes
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for November 30, 2020 AND December 18, 2020
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release included new concepts for COVID treatments, concepts for PIH and MSF plus there were continued concept map changes to combination drugs to add RxNORM maps. The December 18th release contains numerous COVID-19 related concepts required for proper vaccine administration documentation. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
Concepts added for the Nov 30 release:
|"concept_id"|"name"|"Class"|"Datatype"|"description"| |---|---|---|---|---| |"166141"|"Vaginal swab"|"Test"|"Coded"|\N| |"166140"|"Excisional debridement of wound, infection, or burn"|"Procedure"|"N/A"|\N| |"166139"|"Excision of peripheral neuroma"|"Procedure"|"N/A"|\N| |"166139"|"Surgical removal of peripheral neuroma"|"Procedure"|"N/A"|\N| |"166138"|"Excision of head of ulna"|"Procedure"|"N/A"|\N| |"166137"|"HCV viral load, qualitative"|"Test"|"Coded"|\N| |"166136"|"Removal of drain or tube"|"Procedure"|"N/A"|\N| |"166135"|"Insertion of drain or tube"|"Procedure"|"N/A"|\N| |"166134"|"Insertion or replacement of cement spacer"|"Procedure"|"N/A"|\N| |"166133"|"Insertion of tissue expander"|"Procedure"|"N/A"|\N| |"166132"|"Insertion of peripherally inserted central venous catheter (PICC)"|"Procedure"|"N/A"|\N| |"166132"|"Insertion of PICC line"|"Procedure"|"N/A"|\N| |"166131"|"Frontal sinusectomy"|"Procedure"|"N/A"|\N| |"166130"|"Debridement of bone"|"Procedure"|"N/A"|\N| |"166129"|"Bone graft"|"Procedure"|"N/A"|\N| |"166128"|"Biopsy of joint structure"|"Procedure"|"N/A"|\N| |"166127"|"Any seizures since last consultation"|"Question"|"Coded"|\N| |"166126"|"Spirometry"|"Test"|"Coded"|\N| |"166125"|"Clot due to PICC line"|"Diagnosis"|"N/A"|\N| |"166125"|"Venous thrombosis due to peripherally inserted central catheter (PICC)"|"Diagnosis"|"N/A"|\N| |"166124"|"Administration of tetanus vaccine"|"Procedure"|"N/A"|\N| |"166123"|"Serotonin release assay for platelet antibody"|"Test"|"Coded"|\N| |"166123"|"Heparin-induced thrombocytopenia SRA"|"Test"|"Coded"|\N| |"166122"|"Genitourinary tract haemorrhage"|"Diagnosis"|"N/A"|\N| |"166122"|"Genitourinary tract hemorrhage"|"Diagnosis"|"N/A"|\N| |"166122"|"Genitourinary bleeding"|"Diagnosis"|"N/A"|\N| |"166121"|"TNF-alpha inhibitors"|"Pharmacologic Drug Class"|"N/A"|\N| |"166120"|"Simponi"|"Drug"|"N/A"|\N| |"166120"|"Golimumab"|"Drug"|"N/A"|\N| |"166119"|"Certolizumab pegol"|"Drug"|"N/A"|\N| |"166119"|"Cimzia"|"Drug"|"N/A"|\N| |"166118"|"mTOR inhibitors"|"Pharmacologic Drug Class"|"N/A"|\N| |"166117"|"Torisel"|"Drug"|"N/A"|\N| |"166117"|"Temsirolimus"|"Drug"|"N/A"|\N| |"166116"|"Xeljanz"|"Drug"|"N/A"|\N| |"166116"|"Tofacitinib"|"Drug"|"N/A"|\N| |"166115"|"Upadacitinib"|"Drug"|"N/A"|\N| |"166115"|"Rinvoq"|"Drug"|"N/A"|\N| |"166114"|"Janus kinase inhibitors"|"Pharmacologic Drug Class"|"N/A"|\N| |"166114"|"JAK inhibitors"|"Pharmacologic Drug Class"|"N/A"|\N| |"166113"|"Giapreza"|"Drug"|"N/A"|\N| |"166112"|"VASOPRESSIN (USP)"|"Drug"|"N/A"|\N| |"166112"|"Vasostrict"|"Drug"|"N/A"|\N| |"166111"|"Cangrelor"|"Drug"|"N/A"|\N| |"166111"|"Kengreal"|"Drug"|"N/A"|\N| |"166110"|"Prasugrel"|"Drug"|"N/A"|\N| |"166110"|"Effient"|"Drug"|"N/A"|\N| |"166109"|"Ticagrelor"|"Drug"|"N/A"|\N| |"166109"|"Brilinta"|"Drug"|"N/A"|\N| |"166108"|"Edoxaban"|"Drug"|"N/A"|\N| |"166108"|"Savaysa"|"Drug"|"N/A"|\N| |"166107"|"Xarelto"|"Drug"|"N/A"|\N| |"166107"|"Rivaroxaban"|"Drug"|"N/A"|\N| |"166106"|"Eliquis"|"Drug"|"N/A"|\N| |"166106"|"Apixaban"|"Drug"|"N/A"|\N| |"166105"|"Arthrodesis"|"Procedure"|"N/A"|\N| |"166104"|"Co-morbid condition (text)"|"Question"|"Text"|\N| |"166103"|"Surname"|"Question"|"Text"|\N| |"166103"|"Family name"|"Question"|"Text"|\N| |"166103"|"Last name"|"Question"|"Text"|\N| |"166102"|"Forename"|"Question"|"Text"|\N| |"166102"|"Christian name"|"Question"|"Text"|\N| |"166102"|"Given name"|"Question"|"Text"|\N| |"166102"|"First name"|"Question"|"Text"|\N| |"166101"|"National passport"|"Misc"|"N/A"|\N| |"166100"|"Referral to PEPFAR supported site"|"Question"|"Coded"|\N| |"166100"|"Referral to PEPFAR partner site"|"Question"|"Coded"|\N| |"166099"|"Unplanned return to operating room"|"Finding"|"N/A"|\N| |"166099"|"Unplanned return to surgery"|"Finding"|"N/A"|\N| |"166098"|"Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate"|"Diagnosis"|"N/A"|\N| |"166098"|"Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate"|"Diagnosis"|"N/A"|\N| |"166097"|"LY-CoV555"|"Drug"|"N/A"|\N| |"166097"|"Bamlanivimab"|"Drug"|"N/A"|\N| |"166096"|"Examination for unspecified reason"|"Finding"|"N/A"|\N| |"166095"|"Maternal side effect of medication present during pregnancy"|"Question"|"Coded"|\N| |"166094"|"Disruption of traumatic injury wound repair"|"Diagnosis"|"N/A"|\N| |"166093"|"Acute exacerbation of COPD"|"Diagnosis"|"Coded"|\N| |"166093"|"Acute exacerbation of chronic obstructive pulmonary disease"|"Diagnosis"|"Coded"|\N| |"166092"|"Date of exit from cohort"|"Question"|"Date"|\N| |"166091"|"Enrollment date into cohort"|"Question"|"Date"|\N| |"166091"|"Date of entry into cohort"|"Question"|"Date"|\N| |"166090"|"Zaltrap"|"Drug"|"N/A"|"Monoclonal antibodyis indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR)."| |"166090"|"EYLEA"|"Drug"|"N/A"|"Monoclonal antibodyis indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR)."| |"166090"|"Aflibercept"|"Drug"|"N/A"|"Monoclonal antibodyis indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR)."| |"166089"|"INMAZEB"|"Drug"|"N/A"|"Monoclonal antibodies against Zaire Ebolavirus by Regeneron"| |"166089"|"Atoltivimab / maftivimab / odesivimab-ebgn"|"Drug"|"N/A"|"Monoclonal antibodies against Zaire Ebolavirus by Regeneron"| |"166088"|"Casirivimab / imdevimab"|"Drug"|"N/A"|"Monoclonal antibody directed against SARS-CoV-2 by Regeneron"| |"166088"|"REGN-COV2"|"Drug"|"N/A"|"Monoclonal antibody directed against SARS-CoV-2 by Regeneron"| |"166087"|"Dolutegravir / Lamivudine / Zidovudine"|"Misc"|"N/A"|"Antiretroviral regimen"| |"166087"|"DTG + 3TC + AZT"|"Misc"|"N/A"|"Antiretroviral regimen"|
1 Like
Changes with the December 18th release (not yet on OCL):
|"concept_id"|"name"|"Class"|"Datatype"|"description"| |---|---|---|---|---| |"166222"|"Mental or behavioural disorder due to psychoactive substance"|"Diagnosis"|"N/A"|\N| |"166222"|"Mental or behavioral disorder due to psychoactive substance"|"Diagnosis"|"N/A"|\N| |"166221"|"Mental or behavioral disorder due to alcohol use"|"Diagnosis"|"N/A"|\N| |"166221"|"Mental or behavioural disorder due to alcohol use"|"Diagnosis"|"N/A"|\N| |"166220"|"Tendon injury, lower leg"|"Diagnosis"|"N/A"|\N| |"166220"|"Injury to tendon of lower leg"|"Diagnosis"|"N/A"|\N| |"166219"|"Tendon injury, upper leg"|"Diagnosis"|"N/A"|\N| |"166219"|"Injury to tendon of thigh"|"Diagnosis"|"N/A"|\N| |"166218"|"Injury of tendon of hand"|"Diagnosis"|"N/A"|\N| |"166217"|"Fracture of upper arm, open"|"Diagnosis"|"N/A"|\N| |"166217"|"Open fracture of humerus"|"Diagnosis"|"N/A"|\N| |"166216"|"Fracture of upper arm, closed"|"Diagnosis"|"N/A"|\N| |"166216"|"Closed fracture or humerus"|"Diagnosis"|"N/A"|\N| |"166215"|"Mild to moderate depression"|"Diagnosis"|"N/A"|\N| |"166214"|"Disorder of bone density or structure"|"Diagnosis"|"N/A"|\N| |"166213"|"Puerperal psychosis"|"Diagnosis"|"N/A"|\N| |"166212"|"Chronic psychosis"|"Diagnosis"|"N/A"|\N| |"166211"|"Reaction to severe stress"|"Diagnosis"|"N/A"|\N| |"166210"|"Complication associated with peripherally inserted central catheter (PICC)"|"Diagnosis"|"N/A"|\N| |"166209"|"Intraoperative musculoskeletal disorder"|"Diagnosis"|"N/A"|\N| |"166208"|"Postprocedural disorder of musculoskeletal system"|"Diagnosis"|"N/A"|\N| |"166207"|"Soft tissue disorder related to use, overuse, and pressure"|"Diagnosis"|"N/A"|\N| |"166206"|"Cheek"|"Anatomy"|"N/A"|\N| |"166205"|"Cervical vertebra"|"Anatomy"|"N/A"|\N| |"166204"|"Cervical spine"|"Anatomy"|"N/A"|\N| |"166203"|"Carpal joint"|"Anatomy"|"N/A"|\N| |"166202"|"Carpal bones"|"Anatomy"|"N/A"|\N| |"166201"|"Breast"|"Anatomy"|"N/A"|\N| |"166200"|"Country where diagnosed"|"Question"|"Coded"|\N| |"166200"|"Country of diagnosis"|"Question"|"Coded"|\N| |"166199"|"Dried blood spot COVID-19 virus antibody detection by immunoassay"|"Test"|"Coded"|\N| |"166199"|"Dried blood spot severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody detection by immunoassay"|"Test"|"Coded"|\N| |"166199"|"DBS COVID-19 Ab"|"Test"|"Coded"|\N| |"166198"|"detection in serum or plasma of neutralizing antibody to COVID-19 virus spike protein receptor-binding domain by immunoassay"|"Test"|"Coded"|\N| |"166198"|"Detection in serum or plasma of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein receptor-binding domain by immunoassay"|"Test"|"Coded"|\N| |"166197"|"Did not attend second dose of COVID-19 vaccination"|"Finding"|"N/A"|\N| |"166197"|"Did not attend second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination"|"Finding"|"N/A"|\N| |"166196"|"Did not attend first dose of COVID-19 vaccination"|"Finding"|"N/A"|\N| |"166196"|"Did not attend first dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination"|"Finding"|"N/A"|\N| |"166195"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine series declined"|"Finding"|"N/A"|\N| |"166195"|"COVID-19 vaccine series declined"|"Finding"|"N/A"|\N| |"166194"|"COVID-19 vaccine second dose declined"|"Finding"|"N/A"|\N| |"166194"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine second dose declined"|"Finding"|"N/A"|\N| |"166193"|"COVID-19 vaccine first dose declined"|"Finding"|"N/A"|\N| |"166193"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine first dose declined"|"Finding"|"N/A"|\N| |"166192"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine series not completed"|"Finding"|"N/A"|\N| |"166192"|"COVID-19 vaccine series not completed"|"Finding"|"N/A"|\N| |"166192"|"Severe acute respiratory syndrome Coronavirus 2 immunisation course abandoned"|"Finding"|"N/A"|\N| |"166191"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine series not administered"|"Finding"|"N/A"|\N| |"166191"|"COVID-19 vaccine series not administered"|"Finding"|"N/A"|\N| |"166190"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine second dose not administered"|"Finding"|"N/A"|\N| |"166190"|"COVID-19 vaccine second dose not administered"|"Finding"|"N/A"|\N| |"166189"|"COVID-19 vaccine first dose not administered"|"Finding"|"N/A"|\N| |"166189"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine first dose not administered"|"Finding"|"N/A"|\N| |"166188"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine dose not administered"|"Finding"|"N/A"|\N| |"166188"|"COVID-19 vaccine dose not administered"|"Finding"|"N/A"|\N| |"166187"|"COVID-19 vaccine series started"|"Finding"|"N/A"|\N| |"166187"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine series started"|"Finding"|"N/A"|\N| |"166186"|"Vaccination hesitancy by patient"|"Finding"|"N/A"|\N| |"166185"|"Vaccination hesitancy by parent"|"Finding"|"N/A"|\N| |"166184"|"COVID-19 virus RNA test result positive at limit of detection"|"Finding"|"N/A"|\N| |"166184"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA test result positive at limit of detection"|"Finding"|"N/A"|\N| |"166183"|"Post-COVID-19 condition"|"Diagnosis"|"N/A"|\N| |"166182"|"COVID-19 virus RNA test result indeterminate"|"Finding"|"N/A"|\N| |"166182"|"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA test result indeterminate"|"Finding"|"N/A"|\N| |"166181"|"Encounter for screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection"|"Diagnosis"|"N/A"|\N| |"166181"|"Encounter for screening for COVID-19"|"Diagnosis"|"N/A"|\N| |"166180"|"Flublok quadrivalent 2020-2021"|"Drug"|"N/A"|\N| |"166180"|"Influenza A virus A/Hawaii/70/2019 (H1N1) antigen / influenza A virus A/Minnesota/41/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen"|"Drug"|"N/A"|\N| |"166179"|"Flulaval Quadrivalent 2020-2021"|"Drug"|"N/A"|\N| |"166179"|"Fluarix Quadrivalent 2020-2021"|"Drug"|"N/A"|\N| |"166179"|"Fluzone quadrivalent 2020-2021"|"Drug"|"N/A"|\N| |"166179"|"Influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen"|"Drug"|"N/A"|\N| |"166178"|"Fluzone quadrivalent 2020 southern hemisphere"|"Drug"|"N/A"|\N| |"166178"|"Influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen"|"Drug"|"N/A"|\N| |"166177"|"Flublok Quadrivalent 2019-2020"|"Drug"|"N/A"|\N| |"166177"|"Flulaval Quadrivalent 2019-2020"|"Drug"|"N/A"|\N| |"166177"|"Fluarix Quadrivalent 2019-2020"|"Drug"|"N/A"|\N| |"166177"|"Afluria Quadrivalent 2019-2020"|"Drug"|"N/A"|\N| |"166177"|"Fluzone quadrivalent 2019-2020"|"Drug"|"N/A"|\N| |"166177"|"Influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen"|"Drug"|"N/A"|\N| |"166176"|"Brachial plexus"|"Anatomy"|"N/A"|\N| |"166175"|"Upper back"|"Anatomy"|"N/A"|\N| |"166175"|"Posterior thorax"|"Anatomy"|"N/A"|\N| |"166174"|"Axillary nerve"|"Anatomy"|"N/A"|\N| |"166173"|"Upper limb"|"Anatomy"|"N/A"|\N| |"166173"|"Upper extremity"|"Anatomy"|"N/A"|\N| |"166172"|"Neck, anterior"|"Anatomy"|"N/A"|\N| |"166172"|"Throat"|"Anatomy"|"N/A"|\N| |"166172"|"Front of throat"|"Anatomy"|"N/A"|\N| |"166171"|"Volar surface of wrist"|"Anatomy"|"N/A"|\N| |"166171"|"Anterior wrist"|"Anatomy"|"N/A"|\N| |"166171"|"Wrist, volar surface"|"Anatomy"|"N/A"|\N| |"166170"|"Anterior surface of shoulder"|"Anatomy"|"N/A"|\N| |"166170"|"Shoulder, anterior surface"|"Anatomy"|"N/A"|\N| |"166169"|"Elbow, antecubital fossa"|"Anatomy"|"N/A"|\N| |"166169"|"Anterior elbow"|"Anatomy"|"N/A"|\N| |"166168"|"Knee"|"Anatomy"|"N/A"|\N| |"166167"|"Lateral surface of knee"|"Anatomy"|"N/A"|\N| |"166167"|"Knee, lateral surface"|"Anatomy"|"N/A"|\N| |"166166"|"Knee, popliteal fossa"|"Anatomy"|"N/A"|\N| |"166166"|"Posterior surface of knee"|"Anatomy"|"N/A"|\N| |"166165"|"Medial surface of knee"|"Anatomy"|"N/A"|\N| |"166165"|"Knee, medial surface"|"Anatomy"|"N/A"|\N| |"166164"|"Anterior surface of knee"|"Anatomy"|"N/A"|\N| |"166164"|"Knee, anterior surface"|"Anatomy"|"N/A"|\N| |"166164"|"Patellar region of knee"|"Anatomy"|"N/A"|\N| |"166163"|"Posterior surface of ankle"|"Anatomy"|"N/A"|\N| |"166162"|"Anterior surface of ankle"|"Anatomy"|"N/A"|\N| |"166161"|"Ankle"|"Anatomy"|"N/A"|\N| |"166160"|"Acromioclavicular joint"|"Anatomy"|"N/A"|\N| |"166159"|"Achilles tendon"|"Anatomy"|"N/A"|\N| |"166158"|"Acetabulum"|"Anatomy"|"N/A"|\N| |"166157"|"GAMALEYA SPUTNIK V COVID-19 VACCINE"|"Drug"|"N/A"|\N| |"166156"|"AZD1222"|"Drug"|"N/A"|\N| |"166156"|"ASTRAZENECA COVID-19 VACCINE"|"Drug"|"N/A"|\N| |"166155"|"PFIZER-BIONTECH COVID-19 VACCINE"|"Drug"|"N/A"|\N| |"166154"|"MODERNA COVID-19 VACCINE"|"Drug"|"N/A"|\N| |"166153"|"Intramuscular administration of second dose of Gamaleya Sputnik V COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166152"|"Intramuscular administration of first dose of Gamaleya Sputnik V COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166151"|"Intramuscular administration of Gamaleya Sputnik V COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166150"|"Intramuscular administration of second dose of Oxford University-AstraZeneca COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166149"|"Intramuscular administration of first dose of Oxford University-AstraZeneca COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166148"|"Intramuscular administration of Oxford University-AstraZeneca COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166147"|"Intramuscular administration of Pfizer-BioNTech COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166147"|"Intramuscular administration of 30 mcg dose of reconstituted, preservative-free, lipid nanoparticle-encapsulated, spike protein mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine"|"Procedure"|"N/A"|\N| |"166146"|"Intramuscular administration of Moderna COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166146"|"Intramuscular administration of 100 mcg dose of preservative-free, lipid nanoparticle-encapsulated, spike protein mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine"|"Procedure"|"N/A"|\N| |"166145"|"Intramuscular administration of second 30 mcg dose of reconstituted, preservative-free, lipid nanoparticle-encapsulated, spike protein mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine"|"Procedure"|"N/A"|\N| |"166145"|"Intramuscular administration of second dose of Pfizer-BioNTech COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166144"|"Intramuscular administration of second 100 mcg dose of preservative-free, lipid nanoparticle-encapsulated, spike protein mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine"|"Procedure"|"N/A"|\N| |"166144"|"Intramuscular administration of second dose of Moderna COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166143"|"Intramuscular administration of first 30 mcg dose of reconstituted, preservative-free, lipid nanoparticle-encapsulated, spike protein mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine"|"Procedure"|"N/A"|\N| |"166143"|"Intramuscular administration of first dose of Pfizer-BioNTech COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166142"|"Intramuscular administration of first dose of Moderna COVID-19 vaccine"|"Procedure"|"N/A"|\N| |"166142"|"Intramuscular administration of first 100 mcg dose of preservative-free, lipid nanoparticle-encapsulated, spike protein mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine"|"Procedure"|"N/A"|\N|
December 18th release now on OCL! COVID-19 starter set also updated.
1 Like
Just a preview of new content which is available from CIEL to support the latest in vaccination efforts. Currently in dropbox only. It also includes anatomical concepts requested by MSF:
“concept_id” “name” “Class” “Datatype” “description” “166356” “Intramuscular administration of 0.5 mL dose of preservative-free adenovirus type 26 DNA vector vaccine containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein transgene” “Procedure” “N/A” \N “166356” “Intramuscular administration of Janssen COVID-19 vaccine” “Procedure” “N/A” \N “166355” “JNJ-78436735 vaccine” “Drug” “N/A” \N “166355” “JANSSEN COVID-19 VACCINE” “Drug” “N/A” \N “166354” “Infection due to Brazil variant COVID-19” “Diagnosis” “N/A” \N “166354” “Infection due to COVID-19 P.1” “Diagnosis” “N/A” \N “166354” “Infection due to P.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N “166353” “Female genital organ” “Anatomy” “N/A” \N “166352” “Soft tissue of uterus” “Anatomy” “N/A” \N “166351” “Dorsal parametrium” “Anatomy” “N/A” \N “166350” “Lateral parametrium” “Anatomy” “N/A” \N “166349” “Peripheral nerve of upper limb” “Anatomy” “N/A” \N “166348” “Thumb and index finger” “Anatomy” “N/A” \N “166347” “Finger” “Anatomy” “N/A” \N “166346” “Shaft of humerus” “Anatomy” “N/A” \N “166346” “Humeral shaft” “Anatomy” “N/A” \N “166345” “Ilium” “Anatomy” “N/A” \N “166344” “Lateral neck” “Anatomy” “N/A” \N “166343” “Lateral plantar nerve” “Anatomy” “N/A” \N “166342” “Lower leg” “Anatomy” “N/A” \N “166341” “Anterior surface of lower leg” “Anatomy” “N/A” \N “166340” “Lower back” “Anatomy” “N/A” \N “166339” “Lower eyelid” “Anatomy” “N/A” \N “166338” “Lower limb” “Anatomy” “N/A” \N “166338” “Lower extremity” “Anatomy” “N/A” \N “166337” “Peripheral nerve of lower limb” “Anatomy” “N/A” \N “166336” “Lower lip” “Anatomy” “N/A” \N “166335” “Lower jaw” “Anatomy” “N/A” \N “166335” “Mandible” “Anatomy” “N/A” \N “166334” “Lumbar vertebra” “Anatomy” “N/A” \N “166333” “Maxillary nerve” “Anatomy” “N/A” \N “166333” “Maxillary branch of trigeminal nerve” “Anatomy” “N/A” \N “166332” “Medial plantar nerve” “Anatomy” “N/A” \N “166331” “Median nerve” “Anatomy” “N/A” \N “166330” “Metacarpal bone” “Anatomy” “N/A” \N “166329” “Metatarsal” “Anatomy” “N/A” \N “166328” “Mouth” “Anatomy” “N/A” \N “166327” “Neck” “Anatomy” “N/A” \N “166326” “Nose” “Anatomy” “N/A” \N “166325” “Palm” “Anatomy” “N/A” \N “166324” “Patella” “Anatomy” “N/A” \N “166323” “Pelvis” “Anatomy” “N/A” \N “166322” “Perineum” “Anatomy” “N/A” \N “166321” “Peroneal nerve” “Anatomy” “N/A” \N “166320” “Retroauricular sulcus” “Anatomy” “N/A” \N “166319” “Tip of elbow” “Anatomy” “N/A” \N “166319” “Posterior aspect of elbow” “Anatomy” “N/A” \N “166318” “Dorsal surface of wrist” “Anatomy” “N/A” \N “166318” “Dorsal aspect of wrist” “Anatomy” “N/A” \N “166317” “Pubis” “Anatomy” “N/A” \N “166316” “Head of radius” “Anatomy” “N/A” \N “166316” “Radial head” “Anatomy” “N/A” \N “166315” “Radial nerve” “Anatomy” “N/A” \N “166314” “Distal radius” “Anatomy” “N/A” \N “166313” “Proximal radius” “Anatomy” “N/A” \N “166312” “Shaft of radius” “Anatomy” “N/A” \N “166312” “Radial shaft” “Anatomy” “N/A” \N “166311” “Rib” “Anatomy” “N/A” \N “166310” “Sacrum” “Anatomy” “N/A” \N “166309” “Scalp” “Anatomy” “N/A” \N “166308” “Scapula” “Anatomy” “N/A” \N “166307” “Sciatic nerve” “Anatomy” “N/A” \N “166306” “Shoulder” “Anatomy” “N/A” \N “166305” “Shoulder joint” “Anatomy” “N/A” \N “166304” “Cranial bone” “Anatomy” “N/A” \N “166304” “Cranium” “Anatomy” “N/A” \N “166304” “Skull” “Anatomy” “N/A” \N “166303” “Sternoclavicular joint” “Anatomy” “N/A” \N “166302” “Sternum” “Anatomy” “N/A” \N “166301” “Stump” “Anatomy” “N/A” \N “166301” “Amputation stump” “Anatomy” “N/A” \N “166300” “Tarsus” “Anatomy” “N/A” \N “166300” “Tarsal bone” “Anatomy” “N/A” \N “166299” “Thigh” “Anatomy” “N/A” \N “166298” “Anterior surface of thigh” “Anatomy” “N/A” \N “166297” “Posterior surface of thigh” “Anatomy” “N/A” \N “166296” “Thoracic spine” “Anatomy” “N/A” \N “166295” “Thoracic vertebra” “Anatomy” “N/A” \N “166294” “Throat” “Anatomy” “N/A” \N “166294” “Anterior neck” “Anatomy” “N/A” \N “166293” “Thumb” “Anatomy” “N/A” \N “166292” “Distal tibia” “Anatomy” “N/A” \N “166291” “Proximal tibia” “Anatomy” “N/A” \N “166290” “Shaft of tibia” “Anatomy” “N/A” \N “166290” “Tibial shaft” “Anatomy” “N/A” \N “166289” “Tibial nerve” “Anatomy” “N/A” \N “166288” “Toe” “Anatomy” “N/A” \N “166287” “Trachea” “Anatomy” “N/A” \N “166286” “Distal ulna” “Anatomy” “N/A” \N “166285” “Proximal ulna” “Anatomy” “N/A” \N “166284” “Ulnar shaft” “Anatomy” “N/A” \N “166284” “Shaft of ulna” “Anatomy” “N/A” \N “166283” “Ulnar nerve” “Anatomy” “N/A” \N “166282” “Upper arm” “Anatomy” “N/A” \N “166281” “Upper eyelid” “Anatomy” “N/A” \N “166280” “Upper jaw” “Anatomy” “N/A” \N “166280” “Maxilla” “Anatomy” “N/A” \N “166279” “Upper limb” “Anatomy” “N/A” \N “166279” “Upper extremity” “Anatomy” “N/A” \N “166278” “Upper lip” “Anatomy” “N/A” \N “166277” “Wrist” “Anatomy” “N/A” \N “166276” “Urinary bladder” “Anatomy” “N/A” \N “166276” “Bladder” “Anatomy” “N/A” \N “166275” “Cervix uteri” “Anatomy” “N/A” \N “166275” “Uterine cervix” “Anatomy” “N/A” \N “166274” “■■■■■■■■” “Anatomy” “N/A” \N “166273” “Corpus uteri” “Anatomy” “N/A” \N “166273” “Body of uterus” “Anatomy” “N/A” \N “166272” “Fundus of uterus” “Anatomy” “N/A” \N “166271” “Isthmus uteri” “Anatomy” “N/A” \N “166271” “Isthmus of uterus” “Anatomy” “N/A” \N “166270” “Labia of vulva” “Anatomy” “N/A” \N “166269” “Ovary” “Anatomy” “N/A” \N “166268” “Peritoneum” “Anatomy” “N/A” \N “166267” “Placenta” “Anatomy” “N/A” \N “166266” “Frenulum of vulva” “Anatomy” “N/A” \N “166266” “Fourchette of vulva” “Anatomy” “N/A” \N “166265” “Rectum” “Anatomy” “N/A” \N “166264” “Retroperitoneum” “Anatomy” “N/A” \N “166263” “Ureter” “Anatomy” “N/A” \N “166262” “Urethra” “Anatomy” “N/A” \N “166261” “Uterine adnexa” “Anatomy” “N/A” \N “166260” “Uterine ligament” “Anatomy” “N/A” \N “166259” “Uterosacral ligament” “Anatomy” “N/A” \N “166258” “Infection due to South Africa variant COVID-19” “Diagnosis” “N/A” \N “166258” “Infection due to B.1.351 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N “166258” “Infection due to COVID-19 B.1.351” “Diagnosis” “N/A” \N “166257” “Infection due to UK variant COVID-19” “Diagnosis” “N/A” \N “166257” “Infection due to B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N “166257” “Infection due to COVID-19 B.1.1.7” “Diagnosis” “N/A” \N “166256” “Uterus” “Anatomy” “N/A” \N “166255” “Parametrium” “Anatomy” “N/A” \N “166254” “Vulva” “Anatomy” “N/A” \N “166253” “Intramuscular administration of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N “166252” “Intramuscular administration of second dose of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N “166251” “Intramuscular administration of first dose of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N “166250” “BBIBP-CorV COVID-19 vaccine” “Drug” “N/A” \N “166250” “SINOPHARM COVID-19 VACCINE” “Drug” “N/A” \N “166249” “CoronaVac COVID-19 vaccine” “Drug” “N/A” \N “166249” “SINOVAC COVID-19 VACCINE” “Drug” “N/A” \N “166248” “Proximal humerus” “Anatomy” “N/A” \N “166248” “Humerus, proximal” “Anatomy” “N/A” \N “166247” “Humerus, distal” “Anatomy” “N/A” \N “166247” “Distal humerus” “Anatomy” “N/A” \N “166246” “Hip joint” “Anatomy” “N/A” \N “166245” “Hip” “Anatomy” “N/A” \N “166244” “Inguinal region” “Anatomy” “N/A” \N “166244” “Groin” “Anatomy” “N/A” \N “166243” “Gluteal region” “Anatomy” “N/A” \N “166243” “Buttock” “Anatomy” “N/A” \N “166242” “Forehead” “Anatomy” “N/A” “Includes eyebrow” “166242” “Forehead” “Anatomy” “N/A” “incluant les sourcils” “166241” “Forearm” “Anatomy” “N/A” \N “166240” “Foot, dorsal” “Anatomy” “N/A” \N “166240” “Dorsum of foot” “Anatomy” “N/A” \N “166239” “Shaft of fibula” “Anatomy” “N/A” \N “166239” “Fibular shaft” “Anatomy” “N/A” \N “166238” “Fibula, proximal” “Anatomy” “N/A” \N “166238” “Proximal fibula” “Anatomy” “N/A” \N “166237” “Fibula, distal” “Anatomy” “N/A” \N “166237” “Distal fibula” “Anatomy” “N/A” \N “166236” “Shaft of femur” “Anatomy” “N/A” \N “166236” “Femoral shaft” “Anatomy” “N/A” \N “166235” “Proximal femur” “Anatomy” “N/A” \N “166235” “Femur, proximal” “Anatomy” “N/A” \N “166234” “Distal femur” “Anatomy” “N/A” \N “166234” “Femur, distal” “Anatomy” “N/A” \N “166233” “Femoral nerve” “Anatomy” “N/A” \N “166232” “Facial bones” “Anatomy” “N/A” \N “166231” “Elbow” “Anatomy” “N/A” \N “166230” “Ear” “Anatomy” “N/A” \N “166229” “Dorsum of hand” “Anatomy” “N/A” \N “166229” “Dorsal face hand and finger” “Anatomy” “N/A” \N “166228” “Deltoid region” “Anatomy” “N/A” \N “166227” “Commissure of the lips” “Anatomy” “N/A” \N “166227” “Labial commissure” “Anatomy” “N/A” \N “166226” “Coccyx” “Anatomy” “N/A” \N “166225” “Clavicle” “Anatomy” “N/A” \N “166224” “Chin” “Anatomy” “N/A” \N “166223” “Chest wall” “Anatomy” “N/A” \N
1 Like
I just noticed that Talk blanks out certain sensitive anatomical names :-o
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for January 29, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release included new concepts for additional COVID vaccination (so there are now concepts for Moderna, Pfizer, AstraZeneca, Sinopharm, Sputnik V and Janssen vaccines), concepts for the different variants of SARS-CoV-2, concepts for PIH and MSF including additional anatomic sites. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for June 6, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
> |concept_id|name|Class|Datatype|description|
> |---|---|---|---|---|
> |166477|Intramuscular administration of second dose of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166476|Intramuscular administration of first dose of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166475|Intramuscular administration of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166474|CureVac CVnCoV COVID-19 vaccine|Drug|N/A|\N|
> |166473|Patient's feelings regarding need for medication compliance|Question|Text|\N|
> |166472|Plan for dealing with medication side effects|Question|Text|\N|
> |166471|Plan for missed medication doses|Question|Text|\N|
> |166470|Medication administration and reminder tools|Question|Text|\N|
> |166469|Medication management plan|Question|Text|Patient plan for storing and administering medications|
> |166468|Knowledge level: HIV and treatment|Question|Text|Patient's understanding about HIV and treatment (ART)|
> |166467|Patient's rationale for high viral load|Question|Text|Narrative description of patient's explanation for why they have a high viral load.|
> |166466|Patient's feelings/reactions concerning test results|Question|Text|Narrative description of a patient's feelings or reactions to getting test results|
> |166465|Isoniazid / pyrazinamide / rifampin regimen|Misc|N/A|TB regimen including INH, Pyrazinamide and Rifampin (not necessarily in a single pill). For the single pill use Concept 768|
> |166464|HIV self-test performed|Question|Coded|Patient has been tested for HIV using a home-based self test.|
> |166463|Completed course of TB prophylaxis|Question|Coded|\N|
> |166463|Completed course of tuberculosis prophylaxis|Question|Coded|\N|
> |166462|Pneumocystis carinii pneumonia prophylaxis adherence|Question|Coded|Based on actual dispensed drugs, Good=>95%, Fair= 85-94%, Poor=<84%|
> |166462|PCP prophylaxis adherence|Question|Coded|Based on actual dispensed drugs, Good=>95%, Fair= 85-94%, Poor=<84%|
> |166461|Abacavir / Lamivudine / Lopinavir / Tenofovir|Misc|N/A|ART regimen used for HIV treatment|
> |166461|3TC/ABC/LPV/TDF|Misc|N/A|ART regimen used for HIV treatment|
> |166460|3TC/ABC/D4T|Misc|N/A|HIV ART regimen|
> |166460|Abacavir / Lamivudine / Stavudine|Misc|N/A|HIV ART regimen|
> |166459|Etravirine / lamivudine / lopinavir / tenofovir|Misc|N/A|HIV treatment regimen|
> |166459|3TC/ETV/LPV/TDF|Misc|N/A|HIV treatment regimen|
> |166458|Telephone contact/client tracing|Procedure|N/A|\N|
> |166458|Phone contact/client tracing|Procedure|N/A|\N|
> |166457|Physical contact/client tracing|Procedure|N/A|\N|
> |166456|Mode of contact/client tracing|Question|Coded|\N|
> |166455|Test kit lot number|Question|Text|\N|
> |166454|Human immunodeficiency virus testing kit type (text)|Question|Text|\N|
> |166453|Abbott SD Bioline HIV/Syphilis Duo test kit|Medical supply|N/A|\N|
> |166452|First response test kit|Medical supply|N/A|HIV test kit|
> |166452|Premier First Response(R) test kit|Medical supply|N/A|HIV test kit|
> |166451|Determine test kit|Medical supply|N/A|\N|
> |166451|Abbott Determine(R) test kit|Medical supply|N/A|\N|
> |166450|Human immunodeficiency virus testing kit type|Question|Coded|\N|
> |166450|HIV test kit type|Question|Coded|\N|
> |166449|Currently taking tuberculosis prophylaxis|Question|Coded|\N|
> |166449|Currently taking TB prophylaxis|Question|Coded|\N|
> |166448|Kenya differentiated care model type|Question|Coded|The type of medication delivery used in Kenya for HIV ART distribution.|
> |166447|Standard medication pickup following clinician visit|Procedure|N/A|\N|
> |166447|Standard care drug pickup following clinician visit|Procedure|N/A|\N|
> |166447|Standard pharmacy pickup following clinician visit|Procedure|N/A|\N|
> |166446|Fast track for drug pickup without clinician visit|Procedure|N/A|\N|
> |166446|Express medication pickup without clinician visit|Procedure|N/A|\N|
> |166446|Express pharmacy pickup without clinician visit|Procedure|N/A|\N|
> |166445|Facility group medication distribution|Procedure|N/A|\N|
> |166444|Community drug distribution, peer led|Procedure|N/A|\N|
> |166444|Community medication distribution, peer led|Procedure|N/A|\N|
> |166443|Community drug distribution, HCW led|Procedure|N/A|\N|
> |166443|Community medication distribution, healthcare worker led|Procedure|N/A|\N|
> |166442|ENT examination finding (text)|Question|Text|Free text entry for ENT exam findings|
> |166441|Eye examination findings (text)|Question|Text|Free text entry of eye exam findings. For coded answers use 163309|
> |166440|CNS exam performance status|Question|Coded|Was a CNS exam performed?|
> |166439|ENT exam performance status|Question|Coded|Was an ENT exam performed?|
> |166438|Obstructive mass of female genital tract|Diagnosis|N/A|\N|
> |166437|Status post perimortem caesarean section|Diagnosis|N/A|\N|
> |166437|Status post perimortem cesarean section|Diagnosis|N/A|\N|
> |166437|History of postmortem cesarean section|Diagnosis|N/A|\N|
> |166437|s/p perimortem c-section|Diagnosis|N/A|\N|
> |166436|Certificate of COVID-19 immunization/negative status|Misc|N/A|\N|
> |166436|COVID-19 Digital Health Pass|Misc|N/A|\N|
> |166435|COVID-19 clinical status based on WHO classification|Question|Numeric|\N|
> |166434|ETV + RAL + DRV/r|Misc|N/A|ARV regimen|
> |166434|Darunavir / etravirine / raltegravir / ritonavir|Misc|N/A|ARV regimen|
> |166433|Target population type|Question|Coded|\N|
> |166433|Key population type|Question|Coded|\N|
> |166432|Study population type|Question|Coded|\N|
> |166431|Key population|Misc|N/A|\N|
> |166431|Target population|Misc|N/A|\N|
> |166430|General population|Misc|N/A|The overall population of a studied group. A type of population often used as a denominator in an indicator.|
> |166429|History of pelvic reconstructive surgery|Diagnosis|N/A|\N|
> |166429|History of pelvis reconstruction|Diagnosis|N/A|\N|
> |166428|History of cervical cerclage|Diagnosis|N/A|\N|
> |166427|Prior trachelectomy|Diagnosis|N/A|\N|
> |166427|History of amputation of uterine cervix|Diagnosis|N/A|\N|
> |166427|History of trachelectomy|Diagnosis|N/A|\N|
> |166427|Status post removal of cervix|Diagnosis|N/A|\N|
> |166427|History of hysterotrachelectomy|Diagnosis|N/A|\N|
> |166426|History of retained placenta|Finding|N/A|\N|
> |166426|Previous retained placenta|Finding|N/A|\N|
> |166425|Assisted|Misc|N/A|\N|
> |166424|Placenta delivery method|Question|Coded|\N|
> |166423|Presence of prostate specific antigen (qualitative)|Test|Coded|\N|
> |166423|PSA present (qualitative)|Test|Coded|\N|
> |166422|Number of prior neonatal deaths|Question|Numeric|The number of live births who died within the first 28 days of life for an individual mother (prior to this pregnancy)|
> |166421|Adopts modern family planning method immediately post-partum|Question|Coded|\N|
> |166420|Lamivudine / Lopinavir / Tenofovir / Zidovudine|Misc|N/A|Regimen used for HIV|
> |166420|AZT/3TC/LPV/TDF|Misc|N/A|Regimen used for HIV|
> |166419|Placenta delivery method|Finding|Coded|\N|
> |166418|Male sex worker|Misc|N/A|\N|
> |166418|Male prostitute|Misc|N/A|\N|
> |166417|Transwoman|Finding|N/A|\N|
> |166417|Transgendered female|Finding|N/A|\N|
> |166416|Transman|Finding|N/A|\N|
> |166416|Transgendered male|Finding|N/A|\N|
> |166415|Transgender status|Finding|Coded|\N|
> |166414|Immune thrombocytopenia with thrombosis associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination|Diagnosis|N/A|\N|
> |166414|COVID-19 vaccine-associated immune thrombotic thrombocytopenia|Diagnosis|N/A|\N|
> |166413|South Africa variant|Misc|N/A|\N|
> |166413|B.1.351 variant|Misc|N/A|\N|
> |166412|India variant|Misc|N/A|\N|
> |166412|B.1.617 variant|Misc|N/A|\N|
> |166411|UK variant|Misc|N/A|\N|
> |166411|B.1.1.7 variant|Misc|N/A|\N|
> |166410|P.1 variant|Misc|N/A|\N|
> |166410|Brazil variant|Misc|N/A|\N|
> |166409|Wild type|Misc|N/A|Unmodified, non-mutated strain of organism|
> |166408|COVID-19 virus variant type|Question|Coded|\N|
> |166408|Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant type|Question|Coded|\N|
> |166407|Infection due to B.1.617 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
> |166407|Infection due to COVID-19 B.1.617|Diagnosis|N/A|\N|
> |166407|Infection due to India variant COVID-19|Diagnosis|N/A|\N|
> |166406|LY-CoV016|Drug|N/A|\N|
> |166406|Etesevimab|Drug|N/A|\N|
> |166405|Reconstruction of thumb from existing finger|Procedure|N/A|\N|
> |166405|Pollicisation of finger|Procedure|N/A|\N|
> |166404|Plastic repair by z plasty|Procedure|N/A|\N|
> |166403|Application of Plaster of Paris (POP)|Procedure|N/A|\N|
> |166402|Peripheral artery bypass|Procedure|N/A|\N|
> |166402|Peripheral artery shunt|Procedure|N/A|\N|
> |166402|Peripheral arterial bypass|Procedure|N/A|\N|
> |166401|Presence of red blood cells in stool test|Test|Coded|\N|
> |166401|Stool RBCs|Test|Coded|\N|
> |166401|Stool test for erythrocytes|Test|Coded|\N|
> |166400|Reason for caesarean delivery|Question|Coded|\N|
> |166400|Reason for cesarean delivery|Question|Coded|\N|
> |166400|Reason for c-section|Question|Coded|\N|
> |166399|severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibody measurement in serum or plasma by immunoassay (mass/volume)|Test|Numeric|\N|
> |166399|COVID-19 virus IgG antibody measurement in serum or plasma by immunoassay (mass/volume)|Test|Numeric|\N|
> |166398|Cyst of entamoeba|Organism|N/A|\N|
> |166398|Cyst of amoeba|Organism|N/A|\N|
> |166397|Mg|Test|Numeric|\N|
> |166397|Serum magnesium measurement (mg/dL)|Test|Numeric|\N|
> |166396|Fe|Test|Numeric|\N|
> |166396|Serum iron measurement (umol/L)|Test|Numeric|\N|
> |166395|Absolute reticulocyte count|Test|Numeric|\N|
> |166395|ARC|Test|Numeric|\N|
> |166394|Intramuscular administration of Sinopharm-Wuhan COVID-19 vaccine|Procedure|N/A|\N|
> |166393|Intramuscular administration of second dose of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166392|Intramuscular administration of first dose of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166391|Intramuscular administration of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166390|Novavax NVX-COV2373 COVID-19 vaccine|Drug|N/A|\N|
> |166389|Bharat Biotech Covaxin COVID-19 vaccine|Drug|N/A|\N|
> |166388|Intramuscular administration of Bharat Biotech Covaxin COVID-19 vaccine|Procedure|N/A|\N|
> |166387|Intramuscular administration of Chumakov Center KoviVac COVID-19 vaccine|Procedure|N/A|\N|
> |166387|Intramuscular administration of Chumakov Center CoviVac COVID-19 vaccine|Procedure|N/A|\N|
> |166386|Chumakov Center Kovivac COVID-19 vaccine|Drug|N/A|\N|
> |166386|Chumakov Center Covivac COVID-19 vaccine|Drug|N/A|\N|
> |166385|Intramuscular administration of Vector Institute EpiVacCorona COVID-19 vaccine|Procedure|N/A|\N|
> |166384|Vector Institute EpivacCorona COVID-19 vaccine|Drug|N/A|\N|
> |166383|Mono-drug resistant tuberculosis infection|Diagnosis|N/A|\N|
> |166383|Mono-drug resistant TB infection|Diagnosis|N/A|\N|
> |166382|High protein liquid nutritional supplement|Misc|N/A|\N|
> |166382|Pediasure|Misc|N/A|\N|
> |166381|Intramuscular administration of CanSinoBIO Ad5-nCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166381|Intramuscular administration of CanSinoBIO Convidicea COVID-19 vaccine|Procedure|N/A|\N|
> |166380|Intramuscular administration of Sinovac CoronaVac COVID-19 vaccine|Procedure|N/A|\N|
> |166379|Sinopharm-Wuhan COVID-19 vaccine|Drug|N/A|\N|
> |166378|Ad5-nCoV COVID-19 Vaccine|Drug|N/A|\N|
> |166378|Cansino Biologics Convidicea COVID-19 vaccine|Drug|N/A|\N|
> |166377|Fibrinogen activity|Test|Numeric|\N|
> |166377|Fibrinogen assay|Test|Numeric|\N|
> |166376|Plasma TT|Test|Numeric|\N|
> |166376|Plasma thrombin time (seconds)|Test|Numeric|\N|
> |166375|Disseminated intravascular coagulation (DIC) screening panel |LabSet|N/A|\N|
> |166374|Comprehensive metabolic panel|LabSet|N/A|\N|
> |166373|Infection due to B.1.526 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
> |166373|Infection due to COVID-19 B.1.526|Diagnosis|N/A|\N|
> |166372|Application of cartilage graft|Procedure|N/A|\N|
> |166371|Medial condyle of elbow|Anatomy|N/A|\N|
> |166371|Medial condyle of humerus|Anatomy|N/A|\N|
> |166370|Lateral condyle of humerus|Anatomy|N/A|\N|
> |166370|Lateral condyle of elbow|Anatomy|N/A|\N|
> |166369|Dimethicone / pinaverium|Drug|N/A|\N|
> |166368|Disposable menstrual product|Misc|N/A|\N|
> |166367|Relacid|Drug|N/A|\N|
> |166367|Tena Cid|Drug|N/A|\N|
> |166367|Rantac Mps|Drug|N/A|\N|
> |166367|Dimethicone / magaldrate|Drug|N/A|\N|
> |166366|Entresto|Drug|N/A|\N|
> |166366|Sacubitril / valsartan|Drug|N/A|\N|
> |166365|History of traditional medicine practice/procedure|Finding|Coded|\N|
> |166364|Female genital exam finding (text)|Finding|Text|\N|
> |166364|Gynecological examination (text)|Finding|Text|\N|
> |166363|Urological examination (text)|Question|Text|\N|
> |166363|Urinary system finding (text)|Question|Text|\N|
> |166362|Female genital exam finding|Finding|Coded|\N|
> |166362|Gynecological exam finding|Finding|Coded|\N|
> |166361|Duration of alcohol use (years)|Finding|Numeric|\N|
> |166360|Tracheotomy|Procedure|N/A|\N|
> |166359|Sinusectomy|Procedure|N/A|\N|
> |166358|Urinary system findings|Finding|Coded|\N|
> |166358|Urological exam findings|Finding|Coded|\N|
> |166357|Occiput posterior presentation|Finding|N/A|Fetal malposition where back of head presents first posteriorly.|
2 Likes
This version is now published on OCL as well as the COVID-19 starter-set collection.
1 Like
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for July 5, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
| concept_id | name | Class | Datatype | description |
|---|---|---|---|---|
| 166533 | Pharyngotonsillitis | Diagnosis | N/A | \N |
| 166532 | World Health Organization Partograph | ConvSet | N/A | \N |
| 166531 | Pitocin drip dose (drops/min) | Question | Numeric | \N |
| 166531 | Oxytocin drip dose (drops/min) | Question | Numeric | \N |
| 166530 | Pitocin concentration (U/L) | Question | Numeric | \N |
| 166530 | Oxytocin concentration (U/L) | Question | Numeric | \N |
| 166529 | Frequency of uterine contractions within 10 minute period | Question | Numeric | \N |
| 166528 | Descent of fetal head in relation to ischial spines | Question | Numeric | Proportion of head above spines out of 5 |
| 166527 | Fetal moulding score | Question | Coded | \N |
| 166527 | Degree of foetal moulding | Question | Coded | \N |
| 166526 | Alcohol and Drug Abuse Assessment screening results | Question | Coded | \N |
| 166525 | Personal life ambitions | Question | Text | \N |
| 166525 | Personal life ambitions (text) | Question | Text | \N |
| 166524 | PASP (pulmonary artery systolic pressure) | Question | Numeric | \N |
| 166524 | sPAP | Question | Numeric | \N |
| 166524 | Pulmonary artery systolic pressure (mmHg) | Question | Numeric | \N |
| 166523 | Infection due to B.1.617.2 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | Diagnosis | N/A | \N |
| 166523 | Infection due to Delta variant COVID-19 | Diagnosis | N/A | \N |
| 166523 | Infection due to COVID-19 B.1.617.2 | Diagnosis | N/A | \N |
| 166522 | 3TC + DRV/r + RAL + TDF | Misc | N/A | ARV regimen |
| 166522 | Darunavir / Lamivudine / Raltegravir / Ritonavir / Tenofovir | Misc | N/A | ARV regimen |
| 166522 | 3TC/DRV/RAL/RTV/TDF | Misc | N/A | ARV regimen |
| 166521 | 3TC + DTG + DRV/r + TDF | Misc | N/A | ARV regimen |
| 166521 | Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir | Misc | N/A | ARV regimen |
| 166521 | 3TC/DAL/DRV/DTG/RTV | Misc | N/A | ARV regimen |
| 166520 | Ended pregnancy since last visit | Question | Coded | \N |
| 166520 | Terminated pregnancy since last visit | Question | Coded | \N |
| 166519 | Screening not done | Finding | N/A | \N |
| 166519 | Screening not performed | Finding | N/A | \N |
| 166518 | Ineligible for screening | Finding | N/A | \N |
| 166518 | Screening not needed | Finding | N/A | \N |
| 166517 | Shares drug injecting equipment | Finding | N/A | \N |
| 166517 | Shares needles and/or syringes | Finding | N/A | \N |
| 166516 | Unreliable condom use | Finding | N/A | Person uses condoms for sex either inconsistently or never at all. |
| 166515 | Referred for family planning services | Procedure | Coded | \N |
| 166514 | Misuses drugs other than intravenously | Finding | N/A | \N |
| 166514 | Non-intravenous drug user | Finding | N/A | \N |
| 166513 | Female prostitute | Misc | N/A | \N |
| 166513 | Female sex worker | Misc | N/A | \N |
| 166512 | Peer educator | Finding | Coded | \N |
| 166511 | Description of physical abuse | Question | Text | \N |
| 166510 | Year began injecting drugs | Question | Numeric | Calendar year when person began injecting drugs |
| 166510 | Year started IVDU | Question | Numeric | Calendar year when person began injecting drugs |
| 166509 | Year man started having sex with men | Question | Numeric | The first year that a male starting having sex with other men. |
| 166508 | Year started sex work | Question | Numeric | The calendar year that the person began having sex for payment. |
| 166507 | Consent given to contact partner | Finding | Coded | \N |
| 166506 | Name of sexual partner | Question | Text | \N |
| 166505 | Has regular sex partner | Question | Coded | Patient has a regular partner for sexual activity |
| 166504 | Number of IVDU per week | Question | Numeric | Average number of drug injections per week |
| 166504 | Number of drug injection episodes per week | Question | Numeric | Average number of drug injections per week |
| 166503 | Number of drug injection times per day | Question | Numeric | \N |
| 166503 | Number of IVDU per day | Question | Numeric | \N |
| 166502 | Number of anal sex acts per week | Question | Numeric | \N |
| 166501 | Number of sex acts per week | Question | Numeric | Average number of any form of sexual activity per week |
| 166500 | Name of transmission hotspot | Question | Text | Name of location where disease transmission is likely to occur. |
| 166499 | Barber shop/beauty salon | Misc | N/A | \N |
| 166498 | Strip club | Misc | N/A | \N |
| 166497 | Brothel | Misc | N/A | \N |
| 166496 | Hotel | Misc | N/A | \N |
| 166495 | Massage parlor | Misc | N/A | \N |
| 166495 | Massage parlour | Misc | N/A | \N |
| 166494 | Drinking bar | Misc | N/A | Drinking bar without lodging |
| 166493 | Drinking bar with lodging | Misc | N/A | |
| 166493 | Hotel bar | Misc | N/A | |
| 166492 | Casino | Misc | N/A | \N |
| 166491 | Beach | Misc | N/A | \N |
| 166490 | Public park | Misc | N/A | \N |
| 166489 | Derelict building | Misc | N/A | \N |
| 166489 | Uninhabitable building | Misc | N/A | \N |
| 166488 | On the street | Misc | N/A | Location or environment |
| 166488 | In the street | Misc | N/A | Location or environment |
| 166487 | Treatment adherence plan | Question | Text | \N |
| 166486 | Patient benefited from home visit | Question | Coded | \N |
| 166485 | Patient experience with referral (text) | Question | Text | \N |
| 166484 | Patient attended last scheduled appointment | Question | Coded | \N |
| 166483 | Patient treated differently upon disclosure of health status | Finding | Coded | \N |
| 166482 | Patient concerned about accidental disclosure of health status | Finding | Coded | \N |
| 166482 | Patient worried about accidental disclosure of health status | Finding | Coded | \N |
| 166481 | B.1.617.2 variant | Misc | N/A | Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant |
| 166481 | Delta variant | Misc | N/A | Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant |
| 166480 | B.1.429 variant | Misc | N/A | S13I, W152C, L452R, D614G California variant |
| 166479 | B.1.427 variant | Misc | N/A | L452R, D614G California variant |
| 166478 | Resolved Post-Acute Sequelae of SARS-CoV-2 infection (PASC) | Diagnosis | N/A | \N |
| 166478 | Resolved post-COVID-19 syndrome | Diagnosis | N/A | \N |
1 Like
COVID-19 Starter set collection has also been updated for the new release.
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for September 2, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for KenyaEMR, BandaHealth, PIH and COVID-19. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|166654|Suspected HSIL with full extent of lesion visualized|Finding|N/A|\N|
|166654|Suspect HSIL fully seen|Finding|N/A|\N|
|166654|Suspected high grade squamous intraepithelial lesion (HGSIL) with full extent of lesion seen|Finding|N/A|\N|
|166653|Cause of injury, qualitative|Question|Coded|\N|
|166652|Arthrolysis|Procedure|N/A|\N|
|166651|Advancement of flap|Procedure|N/A|\N|
|166650|Volume administered (ml)|Question|Numeric|\N|
|166649|Date of injury|Question|Date|\N|
|166648|Cause of burn|Question|Coded|\N|
|166647|Number of specimen(s) collected|Question|Numeric|\N|
|166647|Number of samples (s) collected|Question|Numeric|\N|
|166646|Associated injury|Question|Coded|\N|
|166645|Aceto-white areas visualized on the cervix|Symptom/Finding|N/A|\N|
|166644|Endocervical curettage performed|Question|Coded|\N|
|166643|Uterine cervix fully visualized|Finding|N/A|\N|
|166643|Uterine cervix fully visualised|Finding|N/A|\N|
|166643|Uterine cervix fully seen|Finding|N/A|\N|
|166642|Uterine cervix not visualized|Finding|N/A|\N|
|166642|Uterine cervix not seen|Finding|N/A|\N|
|166642|Uterine cervix not visualised|Finding|N/A|\N|
|166641|Uterine cervix visibility|Question|Coded|\N|
|166640|Fertility intentions|Question|Coded|\N|
|166639|Initial health education received|Question|Coded|\N|
|166639|Initial health education given|Question|Coded|\N|
|166638|Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Question|Coded|\N|
|166638|COVID-19 test status|Question|Coded|\N|
|166637|Referring facility type, non-coded|Question|Text|\N|
|166636|Referring facility type|Question|Coded|\N|
|166635|Procedure performed (text)|Question|Text|\N|
|166634|Patient does not want to get pregnant|Finding|N/A|\N|
|166634|Patient does not wish to get pregnant|Finding|N/A|\N|
|166633|History of obstetrical complication (text)|Diagnosis|Text|\N|
|166632|Suturing|Procedure|N/A|\N|
|166632|Closure by suture|Procedure|N/A|\N|
|166631|Haemostatic technique (text)|Question|Text|\N|
|166631|Hemostatic technique (text)|Question|Text|\N|
|166631|Hemostasis technique (text)|Question|Text|\N|
|166630|Electrocautery operation|Procedure|N/A|\N|
|166630|Electrocautery procedure|Procedure|N/A|\N|
|166629|Hemostatic technique|Question|Coded|\N|
|166629|Hemostasis technique|Question|Coded|\N|
|166629|Haemostasis technique|Question|Coded|\N|
|166628|Encounter for antenatal care|Diagnosis|N/A|\N|
|166628|Supervision of normal pregnancy|Diagnosis|N/A|\N|
|166627|Encounter for immunization|Diagnosis|N/A|\N|
|166627|Vaccination visit|Diagnosis|N/A|\N|
|166626|Encounter for routine circumcision|Diagnosis|N/A|\N|
|166625|Postpartum visit|Diagnosis|N/A|\N|
|166625|Encounter for routine postpartum follow-up|Diagnosis|N/A|\N|
|166625|Postpartum care follow-up|Diagnosis|N/A|\N|
|166624|On sick leave from work|Diagnosis|N/A|\N|
|166624|Out sick|Diagnosis|N/A|\N|
|166623|Suspected malaria|Diagnosis|N/A|\N|
|166623|Presumptive malaria|Diagnosis|N/A|\N|
|166622|Encounter for screening for human immunodeficiency virus|Diagnosis|N/A|\N|
|166622|Screen for HIV|Diagnosis|N/A|\N|
|166622|Encounter for HIV screening|Diagnosis|N/A|\N|
|166621|Endocervical biopsy|Procedure|N/A|\N|
|166621|Endocervical bx|Procedure|N/A|\N|
|166621|Biopsy of endocervix|Procedure|N/A|\N|
|166620|Loop electrosurgical excision procedure (LEEP) indication|Question|Coded|\N|
|166620|LEEP indication|Question|Coded|\N|
|166619|Suspect HSIL SJC not fully seen|Finding|N/A|\N|
|166619|Suspected high grade squamous intraepithelial lesion (HGSIL) with squamocolumnar junction (SJC) not fully visualized|Finding|N/A|\N|
|166618|Suspect HSIL ext into cervical canal|Finding|N/A|\N|
|166618|Suspected high grade squamous intraepithelial lesion (HGSIL) with lesion extending into the cervical canal|Finding|N/A|\N|
|166617|Suspect HSIL >75% cervix|Finding|N/A|\N|
|166617|Suspected high grade squamous intraepithelial lesion (HGSIL) > 75 % of the cervical surface|Finding|N/A|\N|
|166616|Endocervical curettage|Procedure|N/A|\N|
|166616|Curettage of endocervix|Procedure|N/A|\N|
|166615|Unintentional injury|Diagnosis|N/A|\N|
|166615|Accidental injury|Diagnosis|N/A|\N|
|166614|Tendon injury|Diagnosis|N/A|\N|
|166613|Qualitative blood culture result|Question|Coded|\N|
|166612|Burned due to contact with hot solid object or material|Diagnosis|N/A|\N|
|166612|Burn due to contact with hot surface|Diagnosis|N/A|\N|
|166611|Burn caused by fire|Diagnosis|N/A|\N|
|166611|Burn caused by open flame|Diagnosis|N/A|\N|
|166611|Burn caused by open fire|Diagnosis|N/A|\N|
|166610|Superficial partial thickness burn|Diagnosis|N/A|\N|
|166610|Superficial second degree burn|Diagnosis|N/A|\N|
|166609|Deep second degree burn|Diagnosis|N/A|\N|
|166609|Deep partial thickness burn|Diagnosis|N/A|\N|
|166608|Burn caused by hot liquid|Diagnosis|N/A|\N|
|166608|Hot liquid burn|Diagnosis|N/A|\N|
|166607|Willing to receive reminders/notifications about upcoming appointments|Finding|Coded|\N|
|166606|Patient has access to social support people or network|Question|Coded|\N|
|166605|List of patient's treatment supporters|Question|Text|Narrative list of treatment supporters, including groups, community resources, etc.|
|166604|Admit weight|Finding|Numeric|Body weight on admission to hospital|
|166604|Weight on admission (kg)|Finding|Numeric|Body weight on admission to hospital|
|166603|Frequency of requiring a morning alcoholic drink over past year|Question|Coded|\N|
|166603|Frequency of requiring an alcoholic eye-opener over past year|Question|Coded|\N|
|166602|Frequency of failing to achieve a goal due to alcohol over past year|Question|Coded|\N|
|166601|Frequency of not being able to stop drinking alcohol over past year|Question|Coded|\N|
|166600|How often 6+ alcoholic drinks at one time|Question|Coded|\N|
|166600|Frequency of having six or more alcoholic drinks on one occasion|Question|Coded|\N|
|166599|Patient refused to seek treatment due to fear of stigma|Finding|N/A|\N|
|166598|Challenging situations to administer medications|Question|Text|Text description of challenging/difficult situations where patient has to to take drugs/medications|
|166598|Difficult situations to take medication|Question|Text|Text description of challenging/difficult situations where patient has to to take drugs/medications|
|166597|Patient enrollment category|Question|Coded|\N|
|166596|Transit patient|Misc|N/A|A patient who is being seen outside of their regular care setting temporarily to receive medication refills, etc.|
|166596|Transient patient|Misc|N/A|A patient who is being seen outside of their regular care setting temporarily to receive medication refills, etc.|
|166595|Site of injury|Question|Coded|\N|
|166595|Injury site|Question|Coded|\N|
|166594|Burn site|Question|Coded|\N|
|166593|Total body surface area (TBSA) percent|Question|Numeric|\N|
|166593|TBSA (%)|Question|Numeric|\N|
|166592|Circumferential burn|Question|Coded|\N|
|166591|Trephine biopsy|Test|Coded|\N|
|166590|Patient Health Questionnaire-4 (PHQ-4) score|Question|Numeric|\N|
|166590|PHQ-4 score|Question|Numeric|\N|
|166589|VAS score|Question|Numeric|\N|
|166589|Visual analog scale pain score|Question|Numeric|\N|
|166588|Face, Legs, Activity, Cry, Consolability (FLACC) score|Finding|Numeric|\N|
|166587|Douleur Neuropathique 4 score|Finding|Numeric|\N|
|166587|DN4 score|Finding|Numeric|\N|
|166586|HTS strategy|Question|Coded|\N|
|166586|HIV testing services strategy|Question|Coded|\N|
|166585|Patient testing context|Question|Coded|\N|
|166585|Patient tested as|Question|Coded|\N|
|166584|Couple|Misc|N/A|Two persons together|
|166583|Individual|Misc|N/A|\N|
|166583|Individual person|Misc|N/A|\N|
|166582|Non-provider-initiated HIV testing and counseling|Procedure|N/A|\N|
|166581|Stand-alone voluntary counseling and testing center|Misc|N/A|\N|
|166581|Standalone VCT centre|Misc|N/A|\N|
|166580|WHO|Misc|N/A|\N|
|166580|World Health Organization|Misc|N/A|\N|
|166579|Doctors Without Borders|Misc|N/A|\N|
|166579|MSF|Misc|N/A|\N|
|166578|UNRWA|Misc|N/A|\N|
|166578|United Nations Relief and Works Agency|Misc|N/A|\N|
|166577|Ministry of Health|Misc|N/A|\N|
|166577|MOH|Misc|N/A|\N|
|166576|Non-governmental organization facility|Misc|N/A|\N|
|166576|NGO facility|Misc|N/A|\N|
|166575|DOB|Question|Date|\N|
|166575|Date of birth|Question|Date|\N|
|166575|Birthdate|Question|Date|\N|
|166574|Middle name|Question|Text|\N|
|166573|Medial|Misc|N/A|Anatomic direction as opposed to lateral.|
|166572|Condyloma acuminatum of vagina|Diagnosis|N/A|\N|
|166572|Vaginal condyloma acuminatum|Diagnosis|N/A|\N|
|166571|Vulvar condyloma acuminatum|Diagnosis|N/A|\N|
|166571|Condyloma acuminatum of vulva|Diagnosis|N/A|\N|
|166570|Relationship to index case|Question|Coded|\N|
|166570|Relationship to index client|Question|Coded|\N|
|166569|Diarrhea with dehydration|Diagnosis|N/A|\N|
|166568|Encounter for removal of stitches|Diagnosis|N/A|\N|
|166568|Encounter for removal of sutures|Diagnosis|N/A|\N|
|166567|Sand flea infestation|Diagnosis|N/A|\N|
|166567|Tunga penetrans infestation|Diagnosis|N/A|\N|
|166567|Tungiasis|Diagnosis|N/A|\N|
|166567|Jiggers|Diagnosis|N/A|\N|
|166566|Date of weaning|Question|Date|\N|
|166566|Date child fully weaned|Question|Date|\N|
|166565|Weaning speed|Question|Coded|The speed that the mother weans the child off breastfeeding.|
|166564|Hx bleeding|Finding|N/A|\N|
|166564|Personal history of bleeding|Finding|N/A|\N|
|166564|History of bleeding|Finding|N/A|\N|
|166564|History of hemorrhage|Finding|N/A|\N|
|166563|HIV exposed infant program|Program|N/A|\N|
|166562|Infection due to C.37 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
|166562|Infection due to Lamda variant COVID-19|Diagnosis|N/A|\N|
|166562|Infection due to Peru variant COVID-19|Diagnosis|N/A|\N|
|166562|Infection due to COVID-19 C.37|Diagnosis|N/A|\N|
|166561|C.37 variant|Misc|N/A|\N|
|166561|Lamda variant|Misc|N/A|\N|
|166561|Peru variant|Misc|N/A|\N|
|166560|Biopsy of endocervix|Procedure|N/A|\N|
|166559|Had sexual activity with broken condom|Question|Coded|\N|
|166559|Had sexual activity with burst condom|Question|Coded|\N|
|166558|Partner disease treatment monitoring construct|ConvSet|N/A|\N|
|166557|Disease treatment monitoring construct|ConvSet|N/A|\N|
|166556|Cryptococcal ag test, CSF|Test|Coded|\N|
|166556|Cerebrospinal fluid Cryptococcus antigen assay|Test|Coded|\N|
|166556|Cryptococcal antigen test, CSF|Test|Coded|\N|
|166555|Blood Cryptococcus species antigen assay|Test|Coded|\N|
|166555|Cryptococcal ag test|Test|Coded|\N|
|166555|Cryptococcal antigen test, blood|Test|Coded|\N|
|166554|Vibrio cholerae|Organism|N/A|\N|
|166553|Haemophilus parainfluenzae|Organism|N/A|\N|
|166552|Pseudomonas|Organism|N/A|Genus of organism|
|166551|Avibactam / ceftazidime|Drug|N/A|\N|
|166551|Avycaz|Drug|N/A|\N|
|166550|Antimicrobial drug sensitivity test|Test|N/A|\N|
|166550|Antimicrobial susceptibility test|Test|N/A|\N|
|166550|Antibiotic susceptibility test|Test|N/A|\N|
|166549|Type of organism, non-coded (text)|Question|Text|\N|
|166548|Sensitive to antimicrobial|Finding|N/A|\N|
|166548|Not resistant to antimicrobial|Finding|N/A|\N|
|166547|Intermediate resistant to antimicrobial|Finding|N/A|\N|
|166546|Resistant to antimicrobial|Finding|N/A|\N|
|166545|Resistance level of organism against antimicrobial|Question|Coded|\N|
|166544|Antibiotic tested|Question|Coded|Name of the antimicrobial used for testing|
|166543|Type of organism|Question|Coded|Species of organism|
|166542|Recurrent sex under influence of alcohol|Finding|N/A|\N|
|166541|Reason for negative contact tracing outcome|Question|Coded|\N|
|166541|Reason for failed contact tracing|Question|Coded|\N|
|166540|Contact locations details incorrect|Finding|N/A|\N|
|166540|Contact locations details inaccurate|Finding|N/A|\N|
|166539|Contact details inaccurate|Finding|N/A|\N|
|166539|Contact details incorrect|Finding|N/A|\N|
|166538|Contact location details missing|Finding|N/A|\N|
|166537|Contact details missing|Finding|N/A|Contact name, phone, etc. not available|
|166536|Pre-exposure prophylaxis (PrEP)|Procedure|N/A|\N|
|166535|Pre-exposure prophylaxis (PrEP) status|Question|Coded|\N|
|166534|Eligible for pre-exposure prophylaxis (PrEP)|Finding|N/A|\N|
1 Like
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for October 12, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for KenyaEMR, MSF, PIH and COVID-19 (including new concepts for the antiviral drug and anti-malarial vaccine. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
"concept_id" "name" "Class" "Datatype" "description" "166839" "Tendon transfer" "Procedure" "N/A" \N "166838" "Tendon release" "Procedure" "N/A" \N "166837" "Tendon graft procedure" "Procedure" "N/A" \N "166837" "Tendon grafting" "Procedure" "N/A" \N "166836" "Surgical extraction of tooth" "Procedure" "N/A" \N "166835" "Trephination of cranium" "Procedure" "N/A" \N "166835" "Creation of cranial burr hole" "Procedure" "N/A" \N "166834" "Total ureterectomy" "Procedure" "N/A" \N "166833" "Partial ureterectomy" "Procedure" "N/A" \N "166832" "Gynecological examination" "Procedure" "N/A" \N "166832" "GYN exam" "Procedure" "N/A" \N "166832" "Gynaecological examination" "Procedure" "N/A" \N "166831" "Para-aortic lymphadenectomy" "Procedure" "N/A" \N "166830" "Pelvic lymphadenectomy" "Procedure" "N/A" \N "166829" "Transverse abdominis plane block" "Procedure" "N/A" "Type of peripheral nerve block" "166829" "Transverse abdominis plane (TAP) anesthesia" "Procedure" "N/A" "Type of peripheral nerve block" "166828" "Lymph node ultrasound findings (coded)" "Question" "Coded" \N "166827" "Para-aortic adenopathy" "Finding" "N/A" \N "166827" "Para-aortic lymphadenopathy" "Finding" "N/A" \N "166826" "Bilateral pelvic lymphadenopathy" "Finding" "N/A" \N "166826" "Bilateral pelvic adenopathy" "Finding" "N/A" \N "166825" "Right pelvic lymphadenopathy" "Finding" "N/A" \N "166825" "Right pelvic adenopathy" "Finding" "N/A" \N "166824" "Left pelvic lymphadenopathy" "Finding" "N/A" \N "166824" "Left pelvic adenopathy" "Finding" "N/A" \N "166823" "Renal ultrasound findings (coded)" "Question" "Coded" \N "166822" "Ureter width maximum measurement (mm)" "Question" "Numeric" \N "166822" "Ureter maximum diameter (mm)" "Question" "Numeric" \N "166821" "Stage 1B3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166821" "Stage IB3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166820" "Stage IB2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166820" "Stage 1B2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166819" "Stage IB1" "Misc" "N/A" "" "166819" "Stage IB1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166818" "Endometrial biopsy curette" "Medical supply" "N/A" \N "166817" "New York Heart Association Classification class" "Question" "Coded" \N "166816" "Stage IIIC2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166816" "Stage 3C2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166815" "Stage IIIC1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166815" "Stage 3C1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166814" "Stage IIA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166814" "Stage 2A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166813" "Stage IIA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166813" "Stage 2A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166812" "Stage 1A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166812" "Stage IA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166811" "Stage 1A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166811" "Stage IA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166810" "Full code status" "Finding" "N/A" \N "166810" "For resuscitation" "Finding" "N/A" \N "166809" "Do not intubate (DNI)" "Finding" "N/A" \N "166809" "DNAI" "Finding" "N/A" \N "166809" "Do not attempt intubation" "Finding" "N/A" \N "166808" "Chemical code only" "Finding" "N/A" \N "166808" "Medication code only" "Finding" "N/A" \N "166807" "Resuscitation status" "Question" "Coded" \N "166807" "Advance care plan details" "Question" "Coded" \N "166807" "Advance directives" "Question" "Coded" \N "166806" "Pelvic ultrasound done" "Question" "Coded" \N "166806" "Pelvic ultrasound carried out" "Question" "Coded" \N "166806" "Pelvic ultrasound performed" "Question" "Coded" \N "166805" "International Ovarian Tumor Analysis classification malignant features" "Question" "Coded" \N "166805" "IOTA M-features" "Question" "Coded" \N "166804" "International Ovarian Tumor Analysis classification benign features" "Question" "Coded" \N "166804" "IOTA B-features" "Question" "Coded" \N "166803" "Not involved" "Misc" "N/A" "General descriptor" "166803" "Uninvolved" "Misc" "N/A" "General descriptor" "166802" "Involved" "Misc" "N/A" "General descriptor" "166801" "Parametrial involvement" "Question" "Coded" \N "166801" "Parametrial invasion" "Question" "Coded" \N "166800" "Right ovary length (mm)" "Question" "Numeric" \N "166800" "Right ovary longitudinal measurement (mm)" "Question" "Numeric" \N "166799" "Left ovary longitudinal measurement (mm)" "Question" "Numeric" \N "166799" "Left ovary length (mm)" "Question" "Numeric" \N "166798" "Tumour largest measurement (mm)" "Finding" "Numeric" \N "166798" "Tumor maximum dimension (mm)" "Finding" "Numeric" \N "166797" "Application of skin graft" "Procedure" "N/A" \N "166796" "Skin flap operation" "Procedure" "N/A" \N "166795" "Removal, fingernail or toenail" "Procedure" "N/A" \N "166795" "Removal of nail of digit" "Procedure" "N/A" \N "166794" "Removal of external fixation pin" "Procedure" "N/A" \N "166793" "Removal of external fixation device" "Procedure" "N/A" \N "166792" "Harvest of axial pattern flap of skin" "Procedure" "N/A" \N "166791" "Reconstruction with local flap" "Procedure" "N/A" \N "166790" "Reconstruction procedure" "Procedure" "N/A" \N "166789" "Position of kidney" "Question" "Coded" \N "166788" "Very strong blood flow" "Finding" "N/A" \N "166787" "Smooth multilocular tumor with largest diameter greater than 100 mm" "Finding" "N/A" \N "166787" "Smooth multilocular tumor with largest diameter > 100 mm" "Finding" "N/A" \N "166786" "At least 4 papillary structures" "Finding" "N/A" \N "166786" "At least four papillary structures present" "Finding" "N/A" \N "166785" "Ascites present on ultrasound" "Question" "Coded" \N "166784" "Irregular solid tumor" "Misc" "N/A" \N "166783" "No blood flow" "Finding" "N/A" \N "166783" "Blood flow absent" "Finding" "N/A" \N "166782" "Smooth multilocular tumor with largest diameter less than 100 mm" "Finding" "N/A" \N "166782" "Smooth multilocular tumor with largest diameter < 100 mm" "Finding" "N/A" \N "166781" "Presence of acoustic shadows" "Finding" "N/A" \N "166780" "Solid components with largest diameter < 7 mm" "Finding" "N/A" \N "166779" "Unilocular" "Misc" "N/A" "General descriptor" "166778" "Malignant" "Misc" "N/A" "General descriptor" "166777" "Benign" "Misc" "N/A" "General description" "166776" "IOTA classification" "Question" "Coded" \N "166776" "International Ovarian Tumor Analysis (IOTA) group ultrasound category" "Question" "Coded" \N "166775" "Right ovary description (text)" "Question" "Text" \N "166774" "Left ovary description (text)" "Question" "Text" \N "166773" "Left ovary longitudinal diameter (mm)" "Question" "Numeric" \N "166773" "Left ovary longitudinal measurement (mm)" "Question" "Numeric" \N "166772" "Right ovary appearance" "Question" "Coded" \N "166771" "Left ovary appearance" "Question" "Coded" \N "166770" "Vascularized" "Misc" "N/A" "General descriptor" "166770" "Vascular" "Misc" "N/A" "General descriptor" "166769" "Heterogeneous" "Misc" "N/A" "General descriptor" "166768" "Hypoechogenic" "Misc" "N/A" "General descriptor of appearance on ultrasound" "166768" "Hypoechoic" "Misc" "N/A" "General descriptor of appearance on ultrasound" "166767" "Solid" "Misc" "N/A" "General descriptor" "166766" "Cervical tumor characterization via ultrasound" "Question" "Coded" \N "166765" "Uterus, other finding on ultrasound" "Question" "Text" \N "166764" "Endometrial thickness by ultrasound (mm)" "Question" "Numeric" \N "166764" "Endometrial thickness (mm)" "Question" "Numeric" \N "166763" "Uterus size, transverse diameter (mm)" "Question" "Numeric" \N "166763" "Uterus size, transverse measurement (mm)" "Question" "Numeric" \N "166762" "Uterus size, anteroposterior measurement (mm)" "Question" "Numeric" \N "166762" "Uterus size, anteroposterior diameter (mm)" "Question" "Numeric" \N "166761" "Uterus size, longitudinal diameter (mm)" "Question" "Numeric" \N "166761" "Uterus size, longitudinal measurement (mm)" "Question" "Numeric" \N "166760" "Procurement of skin and subcutaneous tissue for graft or flap" "Procedure" "N/A" \N "166759" "Release of contracture of scar" "Procedure" "N/A" \N "166758" "Quadriceplasty" "Procedure" "N/A" \N "166757" "Prosthetic dental implant" "Procedure" "N/A" \N "166757" "Implantation of dental prosthesis" "Procedure" "N/A" \N "166756" "Posteromedial tendon release of clubfoot" "Procedure" "N/A" \N "166756" "Posteromedial release of calcaneotalar equinovarus" "Procedure" "N/A" \N "166755" "Peripheral nerve neurolysis" "Procedure" "N/A" \N "166754" "Paranasal sinusectomy" "Procedure" "N/A" \N "166753" "Skeletal traction" "Procedure" "N/A" \N "166752" "Osteotomy" "Procedure" "N/A" \N "166751" "Open biopsy soft tissue" "Procedure" "N/A" \N "166750" "Nerve graft" "Procedure" "N/A" \N "166749" "Manipulation under anesthesia" "Procedure" "N/A" \N "166748" "Lysis of adhesions of tendon" "Procedure" "N/A" \N "166748" "Tenolysis" "Procedure" "N/A" \N "166747" "Local subcutaneous pedicled V-Y flap" "Procedure" "N/A" \N "166746" "Local rotation flap" "Procedure" "N/A" \N "166745" "Reconstruction of ligament" "Procedure" "N/A" \N "166744" "Capsulodesis of joint" "Procedure" "N/A" \N "166744" "Capsulodesis" "Procedure" "N/A" \N "166743" "Insertion of intramedullary rod" "Procedure" "N/A" \N "166743" "Internal fixation using intramedullary nail" "Procedure" "N/A" \N "166742" "Application of bioengineered skin graft" "Procedure" "N/A" \N "166742" "Application of biosynthetic skin graft" "Procedure" "N/A" \N "166741" "Injection of steroid into joint" "Procedure" "N/A" \N "166741" "Intra-articular steroid injection" "Procedure" "N/A" \N "166740" "Application of McGregor groin flap" "Procedure" "N/A" \N "166740" "Application of iliofemoral groin flap" "Procedure" "N/A" \N "166739" "Fixation of fracture using pins" "Procedure" "N/A" \N "166738" "Filling of segmental defect by bone transport" "Procedure" "N/A" \N "166737" "Fascial sling for facial weakness" "Procedure" "N/A" \N "166736" "Exploration of nerve" "Procedure" "N/A" \N "166735" "Lengthening of Achilles tendon" "Procedure" "N/A" \N "166735" "Elongation of tendo achilles" "Procedure" "N/A" \N [9:28](https://openmrs.slack.com/archives/D012KKH9G8P/p1634092092000600) "166734" "Epiphysiodesis" "Procedure" "N/A" \N "166733" "Dynamization of external fixator" "Misc" "N/A" \N "166733" "Dynamisation of external fixator" "Misc" "N/A" \N "166732" "Division of flap" "Procedure" "N/A" \N "166731" "Removal of K-wire" "Procedure" "N/A" \N "166731" "Removal of Kirschner wire" "Procedure" "N/A" \N "166730" "Removal of plate from bone" "Procedure" "N/A" \N "166729" "Removal of bone screw" "Procedure" "N/A" \N "166728" "Removal of skin suture or clip" "Procedure" "N/A" \N "166727" "Removal of tissue expander" "Procedure" "N/A" \N "166726" "Tenorrhaphy" "Procedure" "N/A" \N "166726" "Repair of tendon" "Procedure" "N/A" \N "166725" "Revision of amputation stump" "Procedure" "N/A" \N "166724" "Revision of scar" "Procedure" "N/A" \N "166723" "Surgical removal of sequestrum" "Procedure" "N/A" \N "166723" "Sequestrectomy" "Procedure" "N/A" \N "166722" "Maxillary sinusectomy" "Procedure" "N/A" \N "166722" "Sinusectomy, maxillary" "Procedure" "N/A" \N "166721" "Radical vaginal hysterectomy" "Procedure" "N/A" \N "166720" "Radical trachelectomy" "Procedure" "N/A" \N "166719" "Partial vulvectomy" "Procedure" "N/A" \N "166718" "Total vulvectomy" "Procedure" "N/A" \N "166717" "Partial colectomy" "Procedure" "N/A" \N "166717" "Partial vaginectomy" "Procedure" "N/A" \N "166716" "Total colpectomy" "Procedure" "N/A" \N "166716" "Total vaginectomy" "Procedure" "N/A" \N "166715" "Incision and drainage" "Procedure" "N/A" \N "166714" "Dermabrasion" "Procedure" "N/A" \N "166713" "Oral commisuroplasty" "Procedure" "N/A" \N "166712" "Surgical removal of coronoid process of mandible" "Procedure" "N/A" \N "166712" "Coronoidectomy" "Procedure" "N/A" \N "166711" "Adjustment of external fixation device" "Procedure" "N/A" \N "166710" "Change of external fixation device" "Procedure" "N/A" \N "166710" "Replacement of external fixation device" "Procedure" "N/A" \N "166709" "Capsulectomy" "Procedure" "N/A" \N "166708" "Bone lengthening" "Procedure" "N/A" \N "166707" "Local anesthesia by infiltration" "Procedure" "N/A" \N "166706" "Thermocoagulation of cervix" "Procedure" "N/A" \N "166706" "Thermocauterization of cervix" "Procedure" "N/A" \N "166705" "Next consultation to be scheduled (text)" "Question" "Text" \N "166704" "Normal breastfeeding" "Finding" "N/A" \N "166703" "Malaria vaccine" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline" "166703" "Mosquirix" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline" "166703" "RTS,S/AS01 vaccine" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline" "166702" "VIR-7831" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline" "166702" "GSK4182136" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline" "166702" "Sotrovimab" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline" "166701" "P.2 variant" "Misc" "N/A" \N "166701" "Zeta variant" "Misc" "N/A" \N "166700" "Molnupiravir" "Drug" "N/A" \N "166700" "Mjölnir" "Drug" "N/A" \N "166700" "MK-4482" "Drug" "N/A" \N "166699" "Impossible to evaluate" "Misc" "N/A" \N "166699" "Cannot be determined" "Misc" "N/A" \N "166698" "Fluid specimen from wound" "Misc" "N/A" \N "166697" "Specimen from soft tissue" "Misc" "N/A" \N "166696" "Negative-pressure wound therapy system pump" "Medical supply" "N/A" \N "166695" "Penrose drain" "Medical supply" "N/A" \N "166694" "Bone specimen" "Misc" "N/A" \N "166694" "Sample from bone" "Misc" "N/A" \N "166693" "Type of drain" "Question" "Coded" \N "166692" "Anesthetic nurse name" "Question" "Text" \N "166692" "Anesthesia nurse name" "Question" "Text" \N "166691" "Circulating nurse name" "Question" "Text" \N "166690" "Scrub nurse name" "Question" "Text" \N "166690" "OR nurse name" "Question" "Text" \N "166690" "Operating theater nurse name" "Question" "Text" \N "166690" "OT nurse name" "Question" "Text" \N "166689" "Anesthesiologist name" "Question" "Text" \N "166689" "Anesthetist name" "Question" "Text" \N "166688" "Surgeon name" "Question" "Text" \N "166687" "Darunavir / Dolutegravir / Efavirenz / Lamivudine / Ritonavir / Tenofovir" "Misc" "N/A" "Antiretroviral regimen" "166686" "Abacavir / Lamivudine / Raltegravir" "Misc" "N/A" "Antiretroviral regimen" "166685" "Darunavir / Lamivudine / Raltegravir / Ritonavir / Zidovudine" "Misc" "N/A" "Antiretroviral regimen" "166684" "Darunavir / Lamivudine / Raltegravir / Ritonavir / Zidovudine" "Misc" "N/A" "Antiretroviral regimen" "166683" "Abacavir / Darunavir / Lamivudine / Raltegravir / Ritonavir" "Misc" "N/A" "Antiretroviral Regimen" "166682" "Frequency of prior night amnesia over past year" "Question" "Coded" "CAPTION: How often during the last year have you been unable to remember what happened the night before because you had been drinking" "166681" "Frequency of feeling guilty or remorse about drinking over past year" "Question" "Coded" \N "166680" "Drank alcohol prior to current year only" "Question" "Coded" \N "166679" "Drank alcohol in current year" "Question" "Coded" \N "166678" "Number of alcoholic drinks consumed per day" "Question" "Numeric" \N "166677" "Male circumcision status" "Question" "Coded" \N "166676" "Behavioural risk assessment outcome" "Question" "Coded" \N "166676" "Behavioral risk assessment outcome" "Question" "Coded" \N "166675" "Low risk" "Misc" "N/A" "General modifier characterizing low risk" "166674" "High risk" "Misc" "N/A" "General modifier characterizing high risk" "166673" "Severe major depression" "Diagnosis" "N/A" \N "166672" "Severe recurrent major depression" "Diagnosis" "N/A" \N "166671" "Discussion about risk reduction" "Question" "Text" \N "166670" "Contraindications for pre exposure prophylaxis (PrEP)" "Question" "Coded" \N "166669" "Mu variant" "Misc" "N/A" \N "166669" "B.1.621 variant" "Misc" "N/A" \N "166668" "Kappa variant" "Misc" "N/A" \N "166668" "B.1.617.1 variant" "Misc" "N/A" \N "166667" "B.1.526 variant" "Misc" "N/A" \N "166667" "Iota variant" "Misc" "N/A" \N "166666" "B.1.525 variant" "Misc" "N/A" \N "166666" "Eta variant" "Misc" "N/A" \N "166665" "Treatment given" "Question" "Coded" \N "166664" "Result of screening procedure" "Finding" "Coded" \N "166664" "Screening result" "Finding" "Coded" \N "166663" "Screening performed" "Question" "Coded" \N "166662" "Disease or focus of screening" "Question" "Coded" \N "166661" "Screening construct" "ConvSet" "N/A" \N "166660" "COVID-19 booster vaccination" "Procedure" "N/A" \N "166660" "COVID-19 booster shot" "Procedure" "N/A" \N "166660" "COVID-19 booster immunization" "Procedure" "N/A" \N "166660" "Administration of booster severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine" "Procedure" "N/A" \N "166659" "Underlying cause of death" "Question" "Boolean" "The original underlying cause of death in a sequence of causes usually derived from the last cause of death in section I of the WHO death certificate" "166658" "Previous sex without condom" "Question" "Coded" \N "166658" "Had sex without condom" "Question" "Coded" \N "166657" "Willing to take pre-exposure prophylaxis (PrEP)" "Question" "Coded" \N "166656" "Referred for preventative services" "Finding" "Coded" \N "166655" "Pre-exposure prophylaxis (PrEP) plan" "Question" "Coded" \N "166655" "Pre-exposure prophylaxis (PrEP) regimen" "Question" "Coded" \N
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for December 15, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for MSF, PIH and COVID-19 (including new concepts for more international vaccines). Please update your dictionaries. This release also had some clean-up to ensure that it complies to more recent OMRS validation scripts. That means some duplicate names were removed and some duplicate concepts were retired.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
"concept_id" "name" "Class" "Datatype" "description"
"167023" "Left ventricular systolic function" "Question" "Coded" \N
"167023" "Left ventricular ejection fraction" "Question" "Coded" \N
"167022" "Guardian understands patient's disease and prognosis" "Question" "Coded" \N
"167021" "Patient understands their disease and prognosis" "Question" "Coded" \N
"167020" "Precancerous lesion histological grade (text)" "Question" "Text" \N
"167019" "Precancerous cervical lesion histological grade" "Question" "Coded" \N
"167018" "Name of person attending with patient" "Question" "Text" \N
"167017" "Follow-up period" "Question" "Coded" \N
"167016" "12 month follow-up" "Procedure" "N/A" \N
"167016" "Yearly follow-up" "Procedure" "N/A" \N
"167016" "Twelve month follow-up" "Procedure" "N/A" \N
"167015" "Six month follow-up" "Procedure" "N/A" \N
"167015" "6 month follow-up" "Procedure" "N/A" \N
"167014" "4 month follow-up" "Procedure" "N/A" \N
"167014" "Four month follow-up" "Procedure" "N/A" \N
"167013" "3 month follow-up" "Procedure" "N/A" \N
"167013" "Three month follow-up" "Procedure" "N/A" \N
"167012" "2 month follow-up" "Procedure" "N/A" \N
"167012" "Two month follow-up" "Procedure" "N/A" \N
"167011" "Status of call attempt" "Question" "Coded" \N
"167010" "Patient/Guardian tried to contact care team within 14 days of death" "Question" "Coded" \N
"167009" "Patient condition the day before death" "Question" "Coded" \N
"167008" "Patient condition a week before death" "Question" "Coded" \N
"167007" "Feeling down, depressed, or hopeless over past two weeks" "Question" "Coded" \N
"167006" "Little interest or pleasure in doing things over past two weeks" "Question" "Coded" \N
"167005" "Not being able to stop or control worrying over past two weeks" "Question" "Coded" \N
"167004" "Rapid assessment" "Procedure" "N/A" \N
"167003" "Feeling nervous, anxious or on edge over past two weeks" "Question" "Coded" \N
"167002" "Nearly every day" "Misc" "N/A" \N
"167001" "More than half the days" "Misc" "N/A" \N
"167000" "Several days" "Misc" "N/A" \N
"166999" "Ascites severity grade" "Question" "Coded" \N
"166998" "Norton pressure ulcer risk score" "Question" "Numeric" \N
"166997" "Telehealth consultation" "Procedure" "N/A" \N
"166997" "Telehealth visit" "Procedure" "N/A" \N
"166997" "Telemedicine consultation" "Procedure" "N/A" \N
"166996" "Village chief" "Misc" "N/A" \N
"166995" "Successful" "Misc" "N/A" \N
"166994" "Unsuccessful" "Misc" "N/A" \N
"166993" "General inhalation anesthesia using laryngeal mask" "Procedure" "N/A" \N
"166993" "GAL" "Procedure" "N/A" \N
"166992" "Uterine conservation surgery" "Procedure" "N/A" "Procedure for cervical excision which preserves the uterus such as LEEP, conization, trachelectomy"
"166991" "Intravenous induction of general anesthesia" "Procedure" "N/A" \N
"166990" "Type of death/grief support provided" "Question" "Coded" \N
"166989" "Grade 3" "Misc" "N/A" \N
"166989" "Grade III" "Misc" "N/A" \N
"166988" "Grade 2" "Misc" "N/A" \N
"166988" "Grade II" "Misc" "N/A" \N
"166987" "Grade I" "Misc" "N/A" \N
"166987" "Grade 1" "Misc" "N/A" \N
"166986" "Bedside oral exam (BOE) score" "Question" "Numeric" \N
"166985" "Patient died peacefully" "Question" "Coded" \N
"166985" "Patient died comfortably" "Question" "Coded" \N
"166984" "Care team/provider responsive to patient needs" "Question" "Coded" \N
"166984" "Would you say that the team has responded to the patient’s needs" "Question" "Coded" \N
"166983" "Care team/provider responsive to family/guardian needs" "Question" "Coded" \N
"166983" "Would you say that the team has responded to your needs" "Question" "Coded" \N
"166982" "Would you say that the team gave you enough information about the patient’s conditions" "Question" "Coded"\N
"166982" "Sufficiently informed about patient status" "Question" "Coded" \N
"166982" "Sufficiently informed about patient condition" "Question" "Coded" \N
"166981" "Would you say that this experience caused financial stress" "Question" "Coded" \N
"166981" "Financial stress due to experience" "Question" "Coded" \N
"166980" "Would you say that you were stressed from this experience" "Question" "Coded" \N
"166980" "Stressed by experience" "Question" "Coded" \N
"166979" "Would you say that you were tired from this experience" "Question" "Coded" \N
"166979" "Experience tiring" "Question" "Coded" \N
"166978" "Was death expected" "Question" "Coded" \N
"166978" "Death expected" "Question" "Coded" \N
"166977" "Definitely not" "Misc" "N/A" \N
"166976" "Probably not" "Misc" "N/A" \N
"166975" "Reason for failed call" "Question" "Text" \N
"166975" "Reason for unsuccessful call" "Question" "Text" \N
"166975" "Reason for unsuccessful telephone call" "Question" "Text" \N
"166974" "Reason for telephone call" "Question" "Text" \N
"166974" "Reason for phone contact" "Question" "Text" \N
"166974" "Reason for call" "Question" "Text" \N
"166973" "Legal guardian name" "Question" "Text" \N
"166972" "Reason out of medication" "Question" "Text" \N
"166972" "Reason for drug stock out" "Question" "Text" \N
"166971" "Has the patient lacked in stock of drugs in the last 14 days before death" "Question" "Coded" \N
"166971" "Patient ran out of medication within 14 days of death" "Question" "Coded" \N
"166970" "Was the patient admitted to any health facility in the last 14 days before death" "Question" "Coded" \N
"166970" "Death within 14 days of admission to a health facility" "Question" "Coded" \N
"166969" "Location of death (text)" "Question" "Text" \N
"166969" "Place of death (text)" "Question" "Text" \N
"166968" "Place of death" "Question" "Coded" \N
"166968" "Location of death" "Question" "Coded" \N
"166967" "Decubitus ulcer staging" "Question" "Coded" \N
"166967" "Bed sore wound staging" "Question" "Coded" \N
"166967" "Pressure ulcer staging" "Question" "Coded" \N
"166966" "Total radical vulvectomy" "Procedure" "N/A" \N
"166966" "Radical total vulvectomy" "Procedure" "N/A" \N
"166965" "Total vaginal hysterectomy" "Procedure" "N/A" \N
"166964" "Intramuscular administration of ZyCoV-D COVID-19 vaccine" "Procedure" "N/A" \N
"166963" "Cadila Healthcare ZyCov-D COVID-19 vaccine" "Drug" "N/A" \N
"166962" "Intramuscular administration of Soberana-02 COVID-19 vaccine" "Procedure" "N/A" \N
"166961" "FINLAY-FR-1A" "Drug" "N/A" \N
"166961" "Soberana-02 COVID-19 Vaccine" "Drug" "N/A" \N
"166960" "Intramuscular administration of Gamaleya Sputnik Light COVID-19 vaccine" "Procedure" "N/A" \N
"166959" "Gamaleya Sputnik Light COVID-19 vaccine" "Drug" "N/A" "Single dose vaccine based on recombinant adenovirus type 26 (rAd26) vector carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein"
"166958" "Intramuscular administration of COVIran COVID-19 vaccine" "Procedure" "N/A" \N
"166957" "COVIran Barekat COVID-19 vaccine" "Drug" "N/A" \N
"166956" "Intramuscular administration of KCONVAC vaccine" "Procedure" "N/A" \N
"166956" "Intramuscular administration of Minhai COVID-19 vaccine" "Procedure" "N/A" \N
"166955" "Intramuscular administration of QazVac COVID-19 vaccine" "Procedure" "N/A" \N
"166955" "Intramuscular administration of QazCovid-in COVID-19 vaccine" "Procedure" "N/A" \N
"166954" "QazVac" "Drug" "N/A" "COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan."
"166954" "QazCovid-in COVID-19 vaccine" "Drug" "N/A" "COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan."
"166953" "Minhai COVID-19 vaccine" "Drug" "N/A" \N
"166953" "KCONVAC" "Drug" "N/A" \N
"166952" "Left ventricular volume estimated from ultrasound (qualitative)" "Question" "Coded" \N
"166951" "Impaired wound healing" "Finding" "N/A" \N
"166950" "Inferior vena cava findings" "Question" "Coded" \N
"166949" "Moderately dilated inferior vena cava" "Finding" "N/A" \N
"166948" "Severely dilated inferior vena cava" "Finding" "N/A" \N
"166947" "Pericardium findings" "Question" "Coded" \N
"166946" "No pericardial effusion" "Finding" "N/A" \N
"166945" "Minimal pericardial effusion" "Finding" "N/A" \N
"166945" "Mild pericardial effusion" "Finding" "N/A" \N
"166944" "Moderate pericardial effusion" "Finding" "N/A" \N
"166943" "Severe pericardial effusion" "Finding" "N/A" \N
"166942" "Malignancy status" "Question" "Coded" "The status or classification of potential malignancy from benign to confirmed malignancy."
"166941" "Thoracic drainage, closed" "Procedure" "N/A" \N
"166941" "Closed drainage of chest" "Procedure" "N/A" \N
"166940" "Mitral valve findings" "Question" "Coded" \N
"166939" "Corrective osteotomy" "Procedure" "N/A" \N
"166938" "Patient referred to palliative care" "Question" "Coded" \N
"166937" "Care management plan" "Question" "Coded" "Patient's coded care management plan"
"166936" "Atypical behaviour due to pain" "Finding" "N/A" \N
"166936" "Atypical behavior due to pain" "Finding" "N/A" \N
"166935" "ALGOPLUS pain assessment findings" "Question" "Coded" \N
"166934" "Complaints due to pain" "Finding" "N/A" \N
"166933" "Look due to pain" "Finding" "N/A" \N
"166933" "Appearance due to pain" "Finding" "N/A" \N
"166932" "Facial expression due to pain" "Finding" "N/A" "Person shows facial expressions due to pain."
"166931" "Iatrogenic fracture during procedure" "Diagnosis" "N/A" \N
"166931" "Fracture complicating procedure" "Diagnosis" "N/A" \N
"166930" "Chronic nociceptive pain" "Diagnosis" "N/A" \N
"166929" "Right ovary perpendicular dimension (mm)" "Question" "Numeric" \N
"166929" "Right ovary thickness (mm)" "Question" "Numeric" \N
"166928" "Left ovary perpendicular dimension (mm)" "Question" "Numeric" \N
"166928" "Left ovary thickness (mm)" "Question" "Numeric" \N
"166927" "Right ovary hilum-cortex diameter (mm)" "Question" "Numeric" \N
"166926" "Left ovary hilum-cortex diameter (mm)" "Question" "Numeric" \N
"166925" "Chemotherapy type" "Question" "Coded" \N
"166924" "Laparotomy for staging of ovarian cancer" "Procedure" "N/A" \N
"166923" "Total bilateral salpingectomy" "Procedure" "N/A" \N
"166922" "Lymph node dissection" "Procedure" "N/A" \N
"166921" "Wide local excision of vulva" "Procedure" "N/A" \N
"166920" "Palliative chemotherapy" "Procedure" "N/A" \N
"166919" "Adjuvant chemotherapy" "Procedure" "N/A" \N
"166918" "NAC (neo-adjuvant chemotherapy)" "Procedure" "N/A" \N
"166918" "Neo-adjuvant chemotherapy" "Procedure" "N/A" \N
"166917" "Chemotherapy" "Procedure" "N/A" \N
"166916" "GAI" "Procedure" "N/A" \N
"166916" "Endotracheal anesthesia" "Procedure" "N/A" \N
"166916" "Administration of general anesthesia using endotracheal tube" "Procedure" "N/A" \N
"166915" "Open reduction of fracture of bone and internal fixation using wire" "Procedure" "N/A" \N
"166914" "Closed reduction of fracture of bone and internal fixation using wire" "Procedure" "N/A" \N
"166913" "Open reduction of fracture of bone and internal fixation using screw" "Procedure" "N/A" \N
"166912" "Closed reduction of fracture of bone and internal fixation using screw" "Procedure" "N/A" \N
"166911" "Open reduction of fracture and internal fixation with plate" "Procedure" "N/A" \N
"166910" "Closed internal fixation using plate" "Procedure" "N/A" \N
"166910" "Closed reduction of fracture of bone and internal fixation using bone plate" "Procedure" "N/A" \N
"166909" "Adequate" "Misc" "N/A" \N
"166908" "Stage IC3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166908" "Stage 1C3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166907" "Stage IC2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166907" "Stage 1C2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166906" "Stage 1C1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166906" "Stage IC1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166905" "Stage 4A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166905" "Stage IVA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166904" "Stage 4A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166904" "Stage IVA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166903" "Stage 3B2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166903" "Stage IIIB2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166902" "Stage IIIB1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166902" "Stage 3B1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166901" "Stage 3A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166901" "Stage IIIA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166900" "Stage 3A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166900" "Stage IIIA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166899" "Suction drain" "Medical supply" "N/A" \N
"166898" "Suspected stenosis of heart valve" "Finding" "N/A" \N
"166897" "Omicron variant" "Misc" "N/A" \N
"166897" "" "Misc" "N/A" \N
"166897" "B.1.1.529 variant" "Misc" "N/A" \N
"166896" "Number of vaginal pads used per time" "ConvSet" "N/A" \N
"166895" "Number of vaginal pads used" "Question" "Numeric" \N
"166894" "Caesaran section wound healing status" "Question" "Coded" \N
"166893" "C/S scar" "Finding" "N/A" \N
"166893" "Abdominal scar indicative of prior caesarean section" "Finding" "N/A" \N
"166893" "Prior c-section scar" "Finding" "N/A" \N
"166892" "Tingling of skin" "Finding" "N/A" \N
"166891" "Neuropathic pain evaluation questionnaire (DN4)" "Question" "Coded" \N
"166890" "Feeling of electric shocks in body" "Finding" "N/A" "Type of dysesthesia where the patient has the sensation of electrical shocks in a part of the body."
"166889" "Q-M classification" "Question" "Coded" \N
"166889" "Querleu Morrow classification" "Question" "Coded" \N
"166888" "Type C2 - Radical hysterectomy without preservation of autonomic nerves" "Misc" "N/A" \N
"166888" "Type C2" "Misc" "N/A" \N
"166887" "Type C1 - Nerve-preserving radical hysterectomy" "Misc" "N/A" \N
"166887" "Type C1" "Misc" "N/A" \N
"166886" "Type B2" "Misc" "N/A" \N
"166886" "Type B2 - Modified radical hysterectomy with a paracervical lymphadenectomy" "Misc" "N/A" \N
"166885" "Type B1 - Modified radical hysterectomy" "Misc" "N/A" \N
"166885" "Type B1" "Misc" "N/A" \N
"166884" "Type A" "Misc" "N/A" \N
"166884" "Type A - Limited Radical Hysterectomy " "Misc" "N/A" \N
"166883" "Pain Verbal Rating Scale (VRS)" "Misc" "N/A" \N
"166882" "Pain Numerical Rating Scale (NRS)" "Misc" "N/A" \N
"166881" "Location of radiating pain" "Question" "Coded" \N
"166881" "Site of pain radiation" "Question" "Coded" \N
"166880" "ALGOPLUS pain scale" "Misc" "N/A" \N
"166880" "ALGOPLUS pain assessment" "Misc" "N/A" \N
"166879" "Pain scale used" "Question" "Coded" \N
"166878" "Pain etiology" "Question" "Coded" \N
"166878" "Cause of pain" "Question" "Coded" \N
"166877" "PF-07321332 / Ritonavir" "Drug" "N/A" \N
"166877" "PAXLOVID" "Drug" "N/A" \N
"166876" "Pinprick hypoesthesia" "Finding" "N/A" \N
"166875" "Pain caused by light brushing of the skin" "Finding" "N/A" \N
"166875" "Cutaneous allodynia to light brushing" "Finding" "N/A" \N
"166874" "Severely enlarged" "Misc" "N/A" \N
"166873" "Moderately enlarged" "Misc" "N/A" \N
"166872" "Mildly enlarged" "Misc" "N/A" \N
"166871" "Right ventricular volume estimated from ultrasound (qualitative)" "Question" "Coded" \N
"166870" "Application of below elbow back slab" "Procedure" "N/A" \N
"166869" "Unintended removal of implant" "Finding" "N/A" \N
"166869" "Accidental removal of implant" "Finding" "N/A" \N
"166868" "Hypodermic needle" "Medical supply" "N/A" \N
"166867" "Commodity dispense construct" "ConvSet" "N/A" \N
"166866" "Commodity name (coded)" "Question" "Coded" \N
"166866" "Supply type" "Question" "Coded" \N
"166866" "Commodity type" "Question" "Coded" \N
"166865" "Date given" "Question" "Date" \N
"166865" "Date distributed" "Question" "Date" \N
"166865" "Date dispensed" "Question" "Date" \N
"166864" "Number dispensed" "Question" "Numeric" \N
"166864" "Quantity distributed" "Question" "Numeric" \N
"166863" "Syringe, disposable" "Medical supply" "N/A" \N
"166862" "Sexual lubricant" "Medical supply" "N/A" \N
"166862" "Lube" "Medical supply" "N/A" \N
"166861" "HIV self-test kit" "Medical supply" "N/A" \N
"166860" "Atypical behaviour due to pain" "Finding" "N/A" \N
"166860" "Body position due to pain" "Finding" "N/A" \N
"166859" "Neuropraxia" "Diagnosis" "N/A" \N
"166858" "Daklinza" "Drug" "N/A" \N
"166858" "Daclatasvir" "Drug" "N/A" \N
"166857" "Oxytrol" "Drug" "N/A" \N
"166857" "Oxybutynin" "Drug" "N/A" \N
"166856" "ASCVD Risk Score" "Question" "Numeric" "The ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American
College of Cardiology. It is a calculation of your 10-year risk of having a cardiovascular problem, such as a heart
attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use,
diabetic status, and smoking status."
"166856" "Atherosclerotic cardiovascular disease risk score" "Question" "Numeric" "The ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American
College of Cardiology. It is a calculation of your 10-year risk of having a cardiovascular problem, such as a heart
attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use,
diabetic status, and smoking status."
"166855" "Literate" "Question" "Coded" \N
"166855" "Able to read and write" "Question" "Coded" \N
"166854" "Minimum pain score" "Question" "Numeric" \N
"166853" "Maximum pain score" "Question" "Numeric" \N
"166852" "Pain site" "Question" "Coded" \N
"166852" "Site of pain" "Question" "Coded" \N
"166851" "Perioperative acute myocardial infarction" "Diagnosis" "N/A" \N
"166850" "Inflammatory pain" "Finding" "N/A" \N
"166849" "Mechanical pain" "Finding" "N/A" \N
"166848" "Date of report" "Question" "Date" \N
"166848" "Report date" "Question" "Date" \N
"166847" "Incident witnessed by" "Question" "Text" \N
"166846" "Incident reported by" "Question" "Text" \N
"166845" "Multisystem inflammatory syndrome in adult (MIS-A) associated with COVID-19" "Diagnosis" "N/A" \N
"166845" "MIS-A associated with COVID-19" "Diagnosis" "N/A" \N
"166845" "Multisystem inflammatory syndrome associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adult" "Diagnosis" "N/A" \N
"166844" "Touch hypoesthesia" "Finding" "N/A" \N
"166844" "Decreased skin sensation to touch" "Finding" "N/A" \N
"166844" "Tactile hypoaesthesia of skin" "Finding" "N/A" \N
"166844" "Tactile hypesthesia" "Finding" "N/A" \N
"166844" "Tactile hypoesthesia" "Finding" "N/A" \N
"166843" "Break of sterility during operation" "Finding" "N/A" \N
"166843" "Breach of sterile field during procedure" "Finding" "N/A" \N
"166842" "Psychroalgia" "Diagnosis" "N/A" \N
"166842" "Painful feeling of cold" "Diagnosis" "N/A" \N
"166841" "SOF" "Drug" "N/A" \N
"166841" "Sofosbuvir" "Drug" "N/A" \N
"166841" "Sovaldi" "Drug" "N/A" \N
"166840" "Irreversible pulpitis" "Diagnosis" "N/A" \N
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for March 19, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 and 2.5 are pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for MSF, PIH and COVID-19 (including new concepts for more pediatric vaccines). Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
> |concept_id|name|Class|Datatype|description|
> |---|---|---|---|---|
> |167164|Very high|Misc|N/A|\N|
> |167163|Algorithmic result (qualitative)|Question|Coded|\N|
> |167162|Algorithmic result (numeric)|Question|Numeric|\N|
> |167161|Victim of gender-based violence in past three months|Question|Coded|\N|
> |167160|Algorithm result|ConvSet|N/A|\N|
> |167159|Suspected cancer|Diagnosis|Coded|\N|
> |167159|Suspected malignant neoplasm|Diagnosis|Coded|\N|
> |167159|Suspected malignancy|Diagnosis|Coded|\N|
> |167158|Telephone number of referring/ordering clinician|Question|Text|\N|
> |167157|Medication dispense status|ConvSet|N/A|http://hl7.org/fhir/CodeSystem/medicationdispense-status|
> |167156|Declined|Misc|N/A|\N|
> |167156|Refused|Misc|N/A|\N|
> |167155|Stopped|Misc|N/A|\N|
> |167155|Discontinued|Misc|N/A|\N|
> |167154|On hold|Misc|N/A|Status for transiently stopping dosing or dispensing a medication or therapy.|
> |167153|Preparation|Misc|N/A|Status of preparing something for an action such as preparing a medication for dispensing.|
> |167152|Provide supplemental oxygen via high flow nasal cannula|Procedure|N/A|\N|
> |167151|Late fetal heart rate deceleration|Finding|N/A|\N|
> |167151|Late foetal heart rate deceleration|Finding|N/A|\N|
> |167150|Duration of ruptured membranes detail|ConvSet|N/A|\N|
> |167149|Duration of ruptured membranes|Question|Numeric|Numeric value to be associated with duration unit (1732)|
> |167148|Duration of labor detail|ConvSet|N/A|\N|
> |167147|Newborn body colour (non-coded)|Question|Text|\N|
> |167147|Neonatal body color (non-coded)|Question|Text|\N|
> |167146|Eligible for testing|Question|Coded|Patient is eligible to be tested.|
> |167145|Experience of sexual or physical violence in past three months|Question|Coded|Within the last 3 months, has the client experienced either physical or sexual violence?|
> |167144|New sexual partner in last three months|Question|Coded|Has the client had a new sexual partner in the last 3 months?|
> |167143|Priority Population|Misc|N/A|\N|
> |167142|Screening tool construct|ConvSet|N/A|\N|
> |167141|Screening tool score|Question|Text|\N|
> |167141|Assessment tool score|Question|Text|\N|
> |167140|Screening tool name (non-coded)|Question|Text|\N|
> |167139|Screening tool name|Question|Coded|\N|
> |167138|Hyper-vigilance|Finding|N/A|\N|
> |167138|Hypervigilant|Finding|N/A|\N|
> |167137|Disorganized thoughts|Diagnosis|N/A|\N|
> |167137|Disorganized thinking|Diagnosis|N/A|\N|
> |167136|Developmental regression in child|Diagnosis|N/A|\N|
> |167135|Repetitious play|Finding|N/A|\N|
> |167135|Repetitive game play|Finding|N/A|\N|
> |167134|Living conditions|Question|Coded|\N|
> |167133|OR ID|Question|Text|\N|
> |167133|Operating theater identification code|Question|Text|\N|
> |167132|Procedure end date/time|Question|Datetime|\N|
> |167131|County of residence|Question|Text|\N|
> |167130|Homeless due to destruction of residence|Finding|N/A|\N|
> |167130|Homeless due to home destroyed|Finding|N/A|\N|
> |167129|Difficulty reasoning|Diagnosis|N/A|\N|
> |167129|Trouble reasoning|Diagnosis|N/A|\N|
> |167128|Avoidance behavior|Diagnosis|N/A|\N|
> |167128|Avoidant behavior|Diagnosis|N/A|\N|
> |167127|Intrusive thoughts|Diagnosis|N/A|\N|
> |167126|Excessive skin removed during circumcision procedure|Finding|N/A|\N|
> |167125|Sexually transmitted disease (STD) treatment|Procedure|N/A|\N|
> |167124|Shang ring|Medical supply|N/A|\N|
> |167123|Forceps guided circumcision|Procedure|N/A|\N|
> |167122|Dorsal slitting of prepuce|Procedure|N/A|\N|
> |167121|Sleeve resection of prepuce|Procedure|N/A|\N|
> |167120|Device circumcision method|Question|Coded|\N|
> |167119|Conventional circumcision method|Question|Coded|\N|
> |167118|Circumcision method|Question|Coded|\N|
> |167117|Homicidal ideation present|Question|Coded|\N|
> |167116|Judgement level|Question|Coded|\N|
> |167116|Judgement|Question|Coded|\N|
> |167115|Insight level|Question|Coded|\N|
> |167114|Denies homicidal ideation|Finding|N/A|\N|
> |167113|Denies suicidal ideation|Finding|N/A|\N|
> |167112|Thought content|Question|Coded|\N|
> |167111|Flight of ideas|Finding|N/A|\N|
> |167110|Tangential thinking|Finding|N/A|\N|
> |167109|Linear thinking|Finding|N/A|\N|
> |167109|Linear thought process|Finding|N/A|\N|
> |167108|Goal oriented|Finding|N/A|\N|
> |167107|Circumferential thought process|Finding|N/A|\N|
> |167107|Circumferential thinking|Finding|N/A|\N|
> |167106|Thought process|Question|Coded|\N|
> |167105|Flat affect|Finding|N/A|\N|
> |167104|Restricted affect|Finding|N/A|\N|
> |167103|Labile affect|Finding|N/A|\N|
> |167102|Normal affect|Finding|N/A|\N|
> |167101|Affect|Question|Coded|\N|
> |167100|Euthymia|Finding|N/A|\N|
> |167100|Euthymic mood|Finding|N/A|\N|
> |167099|Mood|Question|Coded|\N|
> |167098|Road show|Misc|N/A|Presentation or event to communicate information such as a health topic|
> |167097|Social media|Misc|N/A|Facebook, instagram, twitter, etc.|
> |167096|Printed media|Misc|N/A|\N|
> |167096|Newspaper/magazine|Misc|N/A|\N|
> |167095|Broadcast media|Misc|N/A|\N|
> |167095|Radio/Television|Misc|N/A|\N|
> |167094|Source of health information|Question|Coded|\N|
> |167093|Assent given|Question|Coded|Patients unable to give informed consent due to age or disability must assent rather than give consent.|
> |167092|General appearance exam findings|Question|Coded|\N|
> |167092|Physical appearance exam findings|Question|Coded|\N|
> |167091|Clothed normally|Finding|N/A|\N|
> |167091|Wearing appropriate clothing|Finding|N/A|\N|
> |167091|Appropriate clothing for situation|Finding|N/A|\N|
> |167090|Appropriate weight|Finding|N/A|\N|
> |167090|Normal weight|Finding|N/A|\N|
> |167089|Inappropriately dressed|Finding|N/A|\N|
> |167089| Inappropriate clothing for situation|Finding|N/A|\N|
> |167088|Unkempt appearance|Finding|N/A|\N|
> |167088|Untidy|Finding|N/A|\N|
> |167087|Child behavior problem|Diagnosis|N/A|\N|
> |167087|Child behaviour problem|Diagnosis|N/A|\N|
> |167086|Adult behavior problem|Diagnosis|N/A|\N|
> |167086|Adult behaviour problem|Diagnosis|N/A|\N|
> |167085|Victim of sexual violence|Finding|N/A|\N|
> |167085|Survivor of sexual violence|Finding|N/A|\N|
> |167084|Orientation status|Question|Coded|\N|
> |167083|Oriented to time|Finding|N/A|\N|
> |167082|Oriented to place|Finding|N/A|\N|
> |167081|Oriented to person|Finding|N/A|\N|
> |167080|Feeling constantly worried|Finding|N/A|\N|
> |167079|Follow-up required status|Question|Coded|\N|
> |167079|Follow-up need status|Question|Coded|\N|
> |167078|Neurocognitive problem|Diagnosis|N/A|\N|
> |167078|Neurocognitive disorder|Diagnosis|N/A|\N|
> |167077|AP|Pharmacologic Drug Class|N/A|\N|
> |167077|Antipsychotics|Pharmacologic Drug Class|N/A|\N|
> |167077|Anti-psychotics|Pharmacologic Drug Class|N/A|\N|
> |167076|AD|Pharmacologic Drug Class|N/A|\N|
> |167076|Antidepressants|Pharmacologic Drug Class|N/A|\N|
> |167075|AX|Pharmacologic Drug Class|N/A|\N|
> |167075|Anxiolytics|Pharmacologic Drug Class|N/A|\N|
> |167074|Thoughts that you would be better off dead or of hurting yourself in some way|Question|Coded|\N|
> |167073|Moving or speaking so slowly that other people could have noticed or being so fidgety or restless that you have been moving around lot more than usual|Question|Coded|\N|
> |167072|Trouble concentrating on things such as reading the newspaper or watching television|Question|Coded|\N|
> |167071|Feeling bad about yourself or that you're a failure or have let yourself or your family down|Question|Coded|\N|
> |167070|Poor appetite or overeating over past two weeks|Question|Coded|\N|
> |167069|Feeling tired or having little energy over past two weeks|Question|Coded|\N|
> |167068|Trouble falling or staying asleep, or sleeping too much over past two weeks|Question|Coded|\N|
> |167067|Feeling afraid as if something awful might happen over past two weeks|Question|Coded|\N|
> |167066|Becoming easily annoyed or irritable over past two weeks|Question|Coded|\N|
> |167065|Being so restless that it's hard to sit still over past two weeks|Question|Coded|\N|
> |167064|Trouble relaxing over past two weeks|Question|Coded|\N|
> |167063|Psychiatry IPD|Misc|N/A|\N|
> |167063|Psychiatric inpatient department|Misc|N/A|\N|
> |167063|Inpatient psychiatry department|Misc|N/A|\N|
> |167062|Social worker|Misc|N/A|\N|
> |167061|Psychiatrist|Misc|N/A|\N|
> |167060|In transit/On the move|Finding|N/A|\N|
> |167059|Lives at relatives/friends' place|Finding|N/A|\N|
> |167058|Minor not living with family/guardian|Finding|N/A|\N|
> |167057|Minor living with family/guardian|Finding|N/A|\N|
> |167056|Hopelessness|Finding|N/A|\N|
> |167056|Feeling hopeless|Finding|N/A|\N|
> |167055|Sufficient breast milk production|Finding|N/A|\N|
> |167055|Adequate breast milk production|Finding|N/A|\N|
> |167054|Normal lochia odor|Finding|N/A|\N|
> |167053|Lochia odor|Question|Coded|\N|
> |167052|Involuting fundal height (cm below umbilicus)|Question|Numeric|\N|
> |167052|Uterus level from umbilicus during postpartum involution (cm)|Question|Numeric|\N|
> |167051|OPD mobile|Misc|N/A|\N|
> |167051|Mobile clinic|Misc|N/A|\N|
> |167050|IPD|Misc|N/A|\N|
> |167050|Hospital in-patient department|Misc|N/A|\N|
> |167050|Inpatient department|Misc|N/A|\N|
> |167049|Stable housing|Finding|N/A|\N|
> |167049|Stable accommodation|Finding|N/A|\N|
> |167048|Unstable housing|Finding|N/A|\N|
> |167048|Unstable accommodation|Finding|N/A|\N|
> |167047|Single parent family|Misc|N/A|\N|
> |---|---|---|---|---|
> |167046|No known exposure to tobacco smoke|Finding|N/A|\N|
> |167045|Secondhand tobacco exposure at work|Finding|N/A|\N|
> |167045|Exposed to tobacco smoke at work|Finding|N/A|\N|
> |167045|Second hand tobacco exposure at work|Finding|N/A|\N|
> |167044|Secondhand tobacco exposure at home|Finding|N/A|\N|
> |167044|Second hand tobacco exposure at home|Finding|N/A|\N|
> |167044|Exposed to tobacco smoke at home|Finding|N/A|\N|
> |167043|Restarted sexual intercourse|Question|Coded|\N|
> |167043|Resumed sexual intercourse|Question|Coded|\N|
> |167042|Quantity of lochia (qualitative)|Question|Coded|\N|
> |167041|Pfizer-BioNtech COVID-19 vaccine (infant)|Drug|N/A|For infants 2-5 y.o.|
> |167040|Pfizer-BioNtech COVID-19 vaccine (child)|Drug|N/A|For children 5-11 y.o.|
> |167039|Comirnaty|Drug|N/A|For adolescents 12-16 y.o.|
> |167039|Pfizer-BioNtech COVID-19 vaccine (adolescent)|Drug|N/A|For adolescents 12-16 y.o.|
> |167038|Involution of uterus|Question|Coded|\N|
> |167037|Non-tender uterus|Finding|N/A|\N|
> |167037|Uterus non-tender|Finding|N/A|\N|
> |167036|Tender uterus|Finding|N/A|\N|
> |167035|Findings on palpation of uterus|Question|Coded|\N|
> |167034|Polyvalent crotalidae antivenom|Drug|N/A|\N|
> |167034|Crotalic antivenom|Drug|N/A|\N|
> |167034|Crotalic antivenin|Drug|N/A|\N|
> |167033|Lung surfactant|Drug|N/A|\N|
> |167033|Pulmonary surfactant|Drug|N/A|\N|
> |167032|Loxosceles antivenom|Drug|N/A|\N|
> |167032|Loxoscelism antivenin|Drug|N/A|\N|
> |167032|Recluse spider antivenin|Drug|N/A|\N|
> |167031|Lachesis antivenom|Drug|N/A|\N|
> |167031|Lachesic antivenom|Drug|N/A|\N|
> |167031|Lachesic antivenin|Drug|N/A|\N|
> |167030|Bothropic antivenin|Drug|N/A|\N|
> |167030|Bothrops antivenin|Drug|N/A|\N|
> |167030|Bothropic antivenom|Drug|N/A|\N|
> |167029|isolanid|Drug|N/A|\N|
> |167029|Lanatoside C|Drug|N/A|\N|
> |167028|Erbitux|Drug|N/A|\N|
> |167028|Cetuximab|Drug|N/A|\N|
> |167027|Benznidazole|Drug|N/A|\N|
> |167027|Rochagan|Drug|N/A|\N|
> |167027|Radanil|Drug|N/A|\N|
> |167026|AZD7442|Drug|N/A|\N|
> |167026|Evusheld|Drug|N/A|\N|
> |167026|Cilgavimab / Tixagevimab|Drug|N/A|\N|
> |167025|replace|Drug|N/A|\N|
> |167024|PS|Misc|N/A|A partially-recognized state in the United Nations situated in the Middle East|
> |167024|Palestine|Misc|N/A|A partially-recognized state in the United Nations situated in the Middle East|
> ```
1 Like
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for May 21, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for The WHO ANC DTK, MSF, PIH and COVID-19 (including new concepts for more vaccines). Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release. |concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|167286|Displaced person status|Finding|N/A|\N|
|167286|Displaced due to violent conflict|Finding|N/A|\N|
|167285|Non-violent conflict-related medical condition|Finding|N/A|\N|
|167284|Violent conflict-related medical condition|Finding|N/A|\N|
|167283|Repetitive game play|Finding|N/A|\N|
|167282|Illicit substance use|Finding|N/A|\N|
|167282|Illicit drug use|Finding|N/A|\N|
|167281|Long-acting injectable antipsychotics|Pharmacologic Drug Class|N/A|\N|
|167280|Permission to contact|Question|Coded|\N|
|167280|Authorization to contact|Question|Coded|\N|
|167279|Cause of stress (non-coded)|Question|Text|\N|
|167279|Stressor (text)|Question|Text|\N|
|167278|Stressors|Question|Coded|\N|
|167278|Cause of stress|Question|Coded|\N|
|167277|Therapeutic approach|Question|Text|\N|
|167276|Treatment objectives|Question|Text|\N|
|167276|Therapy objectives|Question|Text|\N|
|167275|Follow-up not required|Finding|N/A|\N|
|167275|Follow-up not needed|Finding|N/A|\N|
|167274|Needs follow-up|Finding|N/A|\N|
|167274|Follow-up required|Finding|N/A|\N|
|167273|Neurocognitive symptoms|Question|Coded|\N|
|167272|Psychosomatic symptoms|Question|Coded|\N|
|167271|Psychotic symptoms|Question|Coded|\N|
|167271|Psychosis symptoms|Question|Coded|\N|
|167270|Child behavioral symptoms|Question|Coded|\N|
|167269|Adult behavioral symptoms|Question|Coded|\N|
|167268|Trauma-related symptoms|Question|Coded|\N|
|167267|Anxiety symptoms|Question|Coded|\N|
|167266|Procedure not performed detail|ConvSet|N/A|\N|
|167265|Procedure/lab name|Question|Coded|Name of procedure or lab not performed or recorded for other reasons than being performed.|
|167264|Intramuscular administration of Minhai Biotechnology KCONVAC COVID-19 vaccine|Procedure|N/A|\N|
|167263|Minhai Biotechnology KCONVAC COVID-19 vaccine|Drug|N/A|\N|
|167262|Reason procedure not performed|Question|Coded|\N|
|167261|Intramuscular administration of Medigen COVID-19 vaccine|Procedure|N/A|\N|
|167260|Medigen COVID-19 vaccine|Drug|N/A|\N|
|167260|MVC-COV1901|Drug|N/A|\N|
|167259|Intramuscular administration of Biological E Limited Corbevax COVID-19 vaccine|Procedure|N/A|\N|
|167258|Biological E Limited Corbevax COVID-19 vaccine|Drug|N/A|Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. REF: https://en.wikipedia.org/wiki/Corbevax|
|167257|Intramuscular administration of Anhui Zhifei Longcom Zifivax COVID-19 vaccine|Procedure|N/A|\N|
|167256|ZF-UZ-VAC-2001|Drug|N/A|Anhui Zhifei Longcom and Institute of Microbiology at the Chinese Academy of Sciences COVID-19 Vaccine|
|167256|Anhui Zhifei Longcom Zifivax COVID-19 vaccine|Drug|N/A|Anhui Zhifei Longcom and Institute of Microbiology at the Chinese Academy of Sciences COVID-19 Vaccine|
|167255|Violence type experienced|Question|Coded|\N|
|167254|Private/safe space unavailable|Finding|N/A|Reason that evaluation not done or care not delivered|
|167253|Trained provider unavailable|Finding|N/A|Reason for evaluation not done or care not delivered|
|167252|Female genital pain|Finding|N/A|\N|
|167251|Pelvic lymphadenopathy|Diagnosis|N/A|\N|
|167251|Pelvic adenopathy|Diagnosis|N/A|\N|
|167250|More than 1 can of caffeinated soda or energy drink|Misc|N/A|\N|
|167249|More than 12 bars (50 g) of chocolate|Misc|N/A|\N|
|167248|More than 4 cups (400 ml) of regular tea|Misc|N/A|\N|
|167247|Provided infant formula|Question|Coded|\N|
|167246|History of previous forceps delivery|Finding|N/A|\N|
|167245|Alcohol use during pregnancy|Finding|N/A|\N|
|167245|Alcohol consumption during pregnancy|Finding|N/A|\N|
|167244|Victim of violence|Finding|N/A|\N|
|167244|Victim of physical violence|Finding|N/A|\N|
|167243|Victim of intimate partner abuse|Finding|Coded|\N|
|167243|Victim of intimate partner violence|Finding|Coded|\N|
|167242|Uterine contractions|Finding|N/A|Presence or complaints of uterine contractions, unspecified as to when in pregnancy.|
|167241|Lives with extended family|Finding|N/A|\N|
|167240|Lives with friends|Finding|N/A|\N|
|167239|Lives with siblings|Finding|N/A|\N|
|167238|Lives with parents|Finding|N/A|\N|
|167237|Increased skin temperature of breast|Finding|N/A|\N|
|167236|Peripheral cyanosis|Finding|N/A|\N|
|167235|Equipment malfunction|Finding|N/A|\N|
|167235|Device broken|Finding|N/A|\N|
|167235|Breast discharge|Finding|N/A|\N|
|167234|Equipment not available|Misc|N/A|\N|
|167234|Breast flushing|Misc|N/A|\N|
|167233|Unable to obtain blood pressure|Finding|Coded|\N|
|167232|Hot temperature|Finding|N/A|\N|
|167232|Hot sensation|Finding|N/A|\N|
|167231|Cold sensation|Finding|N/A|\N|
|167231|Cold temperature|Finding|N/A|\N|
|167230|Pump|Units of Measure|N/A|\N|
|167230|Pump (unit of administration)|Units of Measure|N/A|\N|
|167229|Need for specific test|Question|Coded|\N|
|167229|Need for specific laboratory test|Question|Coded|\N|
|167228|Lab referral tracking|ConvSet|N/A|\N|
|167227|Infection of perineal wound|Diagnosis|N/A|\N|
|167227|Perineum wound infection|Diagnosis|N/A|\N|
|167226|Echocardiogram findings|ConvSet|N/A|\N|
|167225|Medication education performed|Question|Coded|\N|
|167225|Medication training complete|Question|Coded|\N|
|167224|Living situation (text)|Question|Text|Living conditions are also available as coded concept|
|167223|Family educated about patient's illness|Question|Coded|\N|
|167222|History of homicidality|Question|Coded|\N|
|167222|History of homicidal ideation|Question|Coded|\N|
|167221|Have you ever felt you needed a drink first thing in the morning (eye-opener) to steady your nerves or to get rid of a hangover?|Question|Coded|\N|
|167221|Need for alcohol use first thing in the morning|Question|Coded|\N|
|167220|Have you ever felt guilty about drinking?|Question|Coded|\N|
|167220|Guilt about alcohol use|Question|Coded|\N|
|167219|Annoyed when criticized for alcohol use|Question|Coded|\N|
|167219|Have people annoyed you by criticizing your drinking? |Question|Coded|\N|
|167218|Have you ever felt you needed to cut down on your drinking?|Question|Coded|\N|
|167218|Felt need to cut down on alcohol use|Question|Coded|\N|
|167217|Score for CAGE questionnaire for detection of alcoholism|Question|Numeric|\N|
|167216|Performance of CAGE questionnaire for detection of alcoholism|Procedure|N/A|\N|
|167215|CAGE alcohol questionnaire questions|ConvSet|N/A|\N|
|167214|Relationship and involvement with children (text)|Question|Text|\N|
|167213|Common Elements Treatment Approach (CETA) completed|Question|Coded|\N|
|167212|Renal epithelial cells presence in urine sediment by light microscopy|Test|Coded|\N|
|167211|Epithelial cells presence in urine sediment by light microscopy|Test|Coded|\N|
|167210|Erythrocytes in urine sediment by light microscopy (count/HPF)|Test|Numeric|\N|
|167210|RBC in urine sediment by light microscopy per high power field|Test|Numeric|\N|
|167209|WBC in urine sediment by light microscopy per high power field|Test|Numeric|\N|
|167209|Leukocytes in urine sediment by light microscopy (count/HPF)|Test|Numeric|\N|
|167208|Cryptococcus detection in cerebrospinal fluid (CSF) by India ink preparation|Test|Coded|\N|
|167207|Cryptococcus Neoformans (india ink)|Test|Coded|\N|
|167207|Cryptococcus detection by India ink preparation|Test|Coded|\N|
|167206|Biktarvy|Drug|N/A|\N|
|167206|Bictegravir / emtricitabine / tenofovir alafenamide|Drug|N/A|\N|
|167205|Bictegravir|Drug|N/A|\N|
|167204|Veru-111|Drug|N/A|Antiviral used for COVID-19|
|167204|Sabizabulin|Drug|N/A|Antiviral used for COVID-19|
|167203|Ability to concentrate (qualitative)|Question|Coded|\N|
|167203|Level of concentration|Question|Coded|\N|
|167202|Memory status|Question|Coded|\N|
|167202|Memory performance|Question|Coded|\N|
|167201|Type of speech|Question|Coded|\N|
|167200|Impaired speech|Finding|N/A|\N|
|167199|Muted speech|Finding|N/A|\N|
|167198|Pressured speech|Finding|N/A|\N|
|167197|Fast speech|Finding|N/A|\N|
|167196|Soft speech|Finding|N/A|\N|
|167195|Loud speech|Finding|N/A|\N|
|167194|Spontaneous speech|Finding|N/A|\N|
|167193|Attitude toward interview|Question|Coded|\N|
|167192|Seductive behaviour|Finding|N/A|\N|
|167192|Seductive|Finding|N/A|\N|
|167192|Seductive behavior|Finding|N/A|\N|
|167191|Manipulative|Finding|N/A|\N|
|167191|Manipulative behavior|Finding|N/A|\N|
|167191|Manipulative behaviour|Finding|N/A|\N|
|167190|Defensive|Finding|N/A|\N|
|167190|Defensiveness|Finding|N/A|\N|
|167190|Defensive behaviour|Finding|N/A|\N|
|167190|Defensive behavior|Finding|N/A|\N|
|167189|Hostile|Finding|N/A|\N|
|167189|Hostile behavior|Finding|N/A|\N|
|167188|Cooperative|Finding|N/A|\N|
|167187|Gamma hydroxybutyrate (GHB) use|Finding|N/A|\N|
|167186|Hallucinogen use|Finding|N/A|\N|
|167185|Benzodiazepine misuse|Finding|N/A|\N|
|167184|Ayahuasca use|Finding|N/A|Psychedelic plant use|
|167183|Urine protein, 24 hour specimen (g)|Test|Numeric|\N|
|167182|Total lipids measurement (mg/dl)|Test|Numeric|\N|
|167181|Hallucination type|Question|Coded|\N|
|167181|Type of hallucinations|Question|Coded|\N|
|167180|Religious delusion|Finding|N/A|\N|
|167179|Delusion type|Question|Coded|\N|
|167179|Type of delusional disorder|Question|Coded|\N|
|167178|PPBS panel|LabSet|N/A|\N|
|167178|Post-prandial blood glucose panel|LabSet|N/A|\N|
|167177|Post-prandial blood glucose measurement (mg/dL) 2 hours after meal|Test|Numeric|\N|
|167177|PPBS 2 h|Test|Numeric|\N|
|167176|PPBS 1.5 h|Test|Numeric|\N|
|167176|Post-prandial blood glucose measurement (mg/dL) 1.5 hour after meal|Test|Numeric|\N|
|167175|Post-prandial blood glucose measurement (mg/dL) 1 hour after meal|Test|Numeric|\N|
|167174|PPBS 30 m|Test|Numeric|\N|
|167174|Post-prandial blood glucose measurement (mg/dL) 30 minutes after meal|Test|Numeric|\N|
|167174|Post-prandial blood glucose measurement (mg/dL) 1/2 hour after meal|Test|Numeric|\N|
|167173|Glucose, serum 1.5 hrs post 75g oral glucose (mg/dL)|Test|Numeric|\N|
|167173|GTT 1.5 hours test|Test|Numeric|\N|
|167172|Age of sexual partner (years)|Question|Numeric|\N|
|167171|Consent granted for sex|Question|Coded|\N|
|167171|Consent given for sex|Question|Coded|\N|
|167170|Datetime specimen sent to lab|Finding|Datetime|\N|
|167169|Age of oldest child (years)|Test|Numeric|\N|
|167169|Age of eldest child (years)|Test|Numeric|\N|
|167168|One sexual partner|Finding|Coded|\N|
|167168|Monogamous|Finding|Coded|\N|
|167167|Victim of neglect|Finding|N/A|\N|
|167166|Immunohistochemical stain|Test|N/A|\N|
|167166|Immune stain study|Test|N/A|\N|
|167166|Immunohistochemistry test|Test|N/A|\N|
|167165|History of exposure to domestic violence as a child|Diagnosis|Coded|\N|
2 Likes